{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:51:06Z","timestamp":1792086666295,"version":"4.4.0"},"reference-count":325,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-026-00742-6","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:01:16Z","timestamp":1791442876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tourette syndrome"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6296-8306","authenticated-orcid":false,"given":"Valsamma","family":"Eapen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey S.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2208-7058","authenticated-orcid":false,"given":"Carol A.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3893-2922","authenticated-orcid":false,"given":"Jennifer","family":"Vermilion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea E.","family":"Cavanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peristera","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"742_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (American Psychiatric Association, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"742_CR2","unstructured":"World Health Organization. ICD-11: International Classification of Diseases, 11th Revision (WHO, 2024)."},{"key":"742_CR3","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci15060620","volume":"15","author":"JF Baizabal-Carvallo","year":"2025","unstructured":"Baizabal-Carvallo, J. F. & Jankovic, J. Simple and complex phonic tics in Tourette syndrome. Brain Sci. 15, 620 (2025).","journal-title":"Brain Sci."},{"key":"742_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.97","volume":"3","author":"MM Robertson","year":"2017","unstructured":"Robertson, M. M. et al. Gilles de la Tourette syndrome. Nat. Rev. Dis. Primers 3, 16097 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"742_CR5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069346","volume":"376","author":"V Eapen","year":"2022","unstructured":"Eapen, V. & Usherwood, T. Assessing tics in children. BMJ 376, e069346 (2022). This paper is a practice review of assessment and management, including differentiation from commonly co-occurring conditions and consumer perspectives.","journal-title":"BMJ"},{"key":"742_CR6","first-page":"1","volume":"48","author":"TV Fernandez","year":"2025","unstructured":"Fernandez, T. V. Genetics of Tourette syndrome. Psychiatr. Clin. 48, 1\u201313 (2025).","journal-title":"Psychiatr. Clin."},{"key":"742_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpsychires.2016.07.017","volume":"82","author":"M Abdulkadir","year":"2016","unstructured":"Abdulkadir, M. et al. Pre-and perinatal complications in relation to Tourette syndrome and co-occurring obsessive-compulsive disorder and attention-deficit\/hyperactivity disorder. J. Psychiatr. Res. 82, 126\u2013135 (2016).","journal-title":"J. Psychiatr. Res."},{"key":"742_CR8","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.567407","volume":"11","author":"D Martino","year":"2020","unstructured":"Martino, D., Johnson, I. & Leckman, J. F. What does immunology have to do with normal brain development and the pathophysiology underlying Tourette syndrome and related neuropsychiatric disorders? Front. Neurol. 11, 567407 (2020).","journal-title":"Front. Neurol."},{"key":"742_CR9","doi-asserted-by":"publisher","unstructured":"Jin, Y. et al. Altered neurodevelopmental trajectories of brain structure in tourette syndrome and chronic tic disorders. Preprint at medRxiv https:\/\/doi.org\/10.64898\/2026.05.16.26353368 (2026).","DOI":"10.64898\/2026.05.16.26353368"},{"key":"742_CR10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2147\/NDT.S72284","volume":"11","author":"V Eapen","year":"2015","unstructured":"Eapen, V. & Robertson, M. M. Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics. Neuropsychiatr. Dis. Treat. 11, 1431\u20131436 (2015).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"742_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/YCO.0000000000001068","volume":"39","author":"C McHugh","year":"2026","unstructured":"McHugh, C., John, J., Wu, W. T. & Eapen, V. The spectrum of neurodevelopmental disorders: comorbidities as clues to pathogenesis. Curr. Opin. Psychiatry 39, 91\u2013102\u00a0https:\/\/doi.org\/10.1097\/YCO.0000000000001068 (2026).","journal-title":"Curr. Opin. Psychiatry"},{"key":"742_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajmg.b.33068","volume":"201","author":"JJ Zouki","year":"2025","unstructured":"Zouki, J. J., Wu, W. T., Stylianakis, A. & Eapen, V. Genetic underpinnings of obsessive\u2013compulsive disorder with and without tics: implications of genetic heterogeneity on clinical management. Am. J. Med. Genet. B\u00a0201, 159\u2013179 (2025).","journal-title":"Am. J. Med. Genet. B"},{"key":"742_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/mdc3.13932","volume":"11","author":"KR M\u00fcller-Vahl","year":"2024","unstructured":"M\u00fcller-Vahl, K. R. et al. Functional tic-like behaviors: a common comorbidity in patients with Tourette syndrome. Mov. Disord. Clin. Pract. 11, 227\u2013237 https:\/\/doi.org\/10.1002\/mdc3.13932 (2024).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR14","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s10578-023-01656-0","volume":"56","author":"KH Watson","year":"2024","unstructured":"Watson, K. H. et al. The association of quality of life with psychosocial factors in adolescents with Tourette syndrome. Child Psychiatry Hum. Dev. 56, 1586\u20131597 (2024).","journal-title":"Child Psychiatry Hum. Dev."},{"key":"742_CR15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/mdc3.13731","volume":"10","author":"S Willford","year":"2023","unstructured":"Willford, S. & Deeb, W. Scoping review of multidisciplinary care in Tourette syndrome. Mov. Disord. Clin. Pract. 10, 868\u2013877 (2023).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR16","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s13311-020-00914-6","volume":"17","author":"A Billnitzer","year":"2020","unstructured":"Billnitzer, A. & Jankovic, J. Current management of tics and Tourette syndrome: behavioral, pharmacologic, and surgical treatments. Neurotherapeutics 17, 1681\u20131693 (2020).","journal-title":"Neurotherapeutics"},{"key":"742_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2022.08.010","volume":"137","author":"F Jafari","year":"2022","unstructured":"Jafari, F., Abbasi, P., Rahmati, M., Hodhodi, T. & Kazeminia, M. Systematic review and meta-analysis of Tourette syndrome prevalence; 1986 to 2022. Pediatr. Neurol. 137, 6\u201316 (2022).","journal-title":"Pediatr. Neurol."},{"key":"742_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","volume":"47","author":"T Knight","year":"2012","unstructured":"Knight, T. et al. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr. Neurol. 47, 77\u201390 (2012).","journal-title":"Pediatr. Neurol."},{"key":"742_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mds.26089","volume":"30","author":"JM Scharf","year":"2015","unstructured":"Scharf, J. M. et al. Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov. Disord. 30, 221\u2013228 https:\/\/doi.org\/10.1002\/mds.26089 (2015).","journal-title":"Mov. Disord."},{"key":"742_CR20","volume":"95","author":"C Yang","year":"2016","unstructured":"Yang, C., Zhang, L., Zhu, P., Zhu, C. & Guo, Q. The prevalence of tic disorders for children in China: a systematic review and meta-analysis. Medicine 95, e4354 (2016).","journal-title":"Medicine"},{"key":"742_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-014-0553-8","volume":"24","author":"HO Atladottir","year":"2015","unstructured":"Atladottir, H. O. et al. The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison. Eur. Child Adolesc. Psychiatry 24, 173\u2013183 (2015).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"742_CR22","volume":"15","author":"AY Yilmaz","year":"2025","unstructured":"Yilmaz, A. Y. & Jankovic, J. Epidemiology of Tourette syndrome. Brain Sci. 15, 426 (2025).","journal-title":"Brain Sci."},{"key":"742_CR23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/23794925.2023.2253544","volume":"9","author":"C Striley","year":"2024","unstructured":"Striley, C., Black, K. J., Chichetto, N. E. & Vagelakos, L. Door-to-door video-enhanced prevalence study of Tourette disorder among African Americans. Evid. Based Pract. Child Adolesc. Ment. Health 9, 281\u2013295 (2024).","journal-title":"Evid. Based Pract. Child Adolesc. Ment. Health"},{"key":"742_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/camh.12370","volume":"26","author":"A Rodin","year":"2021","unstructured":"Rodin, A., Fleetwood-Meade, K., Gilmour, J., Kasujja, R. & Murphy, T. Why don\u2019t children in Uganda have tics? A mixed-methods study of beliefs, knowledge, and attitudes of health professionals. Child Adolesc. Ment. Health 26, 47\u201353 (2021).","journal-title":"Child Adolesc. Ment. Health"},{"key":"742_CR25","volume":"331","author":"S Kim","year":"2024","unstructured":"Kim, S., Kim, M.-S., Kim, J. & Hong, S.-B. Incidence trend and epidemiology of tic disorders among youths and adults in Korea from 2003 to 2020: a national population-based study. Psychiatry Res. 331, 115634 (2024).","journal-title":"Psychiatry Res."},{"key":"742_CR26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaac.2011.11.004","volume":"51","author":"JM Scharf","year":"2012","unstructured":"Scharf, J. M., Miller, L. L., Mathews, C. A. & Ben-Shlomo, Y. Prevalence of Tourette syndrome and chronic tics in the population-based Avon Longitudinal Study of Parents and Children cohort. J. Am. Acad. Child Adolesc. Psychiatry 51, 192\u2013201.e5 (2012).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"742_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109675","volume":"95","author":"JL Levine","year":"2019","unstructured":"Levine, J. L., Szejko, N. & Bloch, M. H. Meta-analysis: adulthood prevalence of Tourette syndrome. Prog. Neuropsychopharmacol. Biol. Psychiatry 95, 109675 (2019).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"742_CR28","volume":"104","author":"ME Dy-Hollins","year":"2025","unstructured":"Dy-Hollins, M. E. et al. Sex differences in natural history and health outcomes among individuals with tic disorders. Neurology 104, e210249 (2025). This paper presents a relevant in-depth analysis of a large consortium dataset documenting that the likelihood to, and latency of, diagnosis of tic disorders differs between female and male individuals.","journal-title":"Neurology"},{"key":"742_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00787-021-01751-4","volume":"31","author":"B Garcia-Delgar","year":"2022","unstructured":"Garcia-Delgar, B. et al. Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group. Eur. Child Adolesc. Psychiatry 31, 1539\u20131548 (2022).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"742_CR30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/dmcn.15088","volume":"64","author":"J Girgis","year":"2022","unstructured":"Girgis, J., Martino, D. & Pringsheim, T. Influence of sex on tic severity and psychiatric comorbidity profile in patients with pediatric tic disorder. Dev. Med. Child Neurol. 64, 488\u2013494 (2022).","journal-title":"Dev. Med. Child Neurol."},{"key":"742_CR31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0883073820967518","volume":"36","author":"JF Garris","year":"2021","unstructured":"Garris, J. F., Huddleston, D. A., Jackson, H. S., Horn, P. S. & Gilbert, D. L. Implementation of the mini-child Tourette syndrome impairment scale: relationships to symptom severity and treatment decisions. J. Child Neurol. 36, 288\u2013295 (2021).","journal-title":"J. Child Neurol."},{"key":"742_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1440366","volume":"13","author":"Y-F Lee","year":"2025","unstructured":"Lee, Y.-F., Wu, M.-C., Huang, Y.-C., Huang, J.-Y. & Wei, J. C.-C. Maternal autoimmune diseases and the risk of tics and Tourette\u2019s disorder in offspring: insights from Taiwan\u2019s real-world data. Front. Pediatr. 13, 1440366 https:\/\/doi.org\/10.3389\/fped.2025.1440366 (2025).","journal-title":"Front. Pediatr."},{"key":"742_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40474-021-00231-3","volume":"8","author":"KJ Black","year":"2021","unstructured":"Black, K. J., Kim, S., Yang, N. Y. & Greene, D. J. Course of tic disorders over the lifespan. Curr. Dev. Disord. Rep. 8, 121\u2013132 (2021).","journal-title":"Curr. Dev. Disord. Rep."},{"key":"742_CR34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","volume":"28","author":"JF Leckman","year":"1989","unstructured":"Leckman, J. F. et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J. Am. Acad. Child Adolesc. Psychiatry 28, 566\u2013573 (1989).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"742_CR35","unstructured":"Shapiro, A. K., Shapiro, E. S., Young, J. G. & Feinberg, T. E. (eds) Gilles de la Tourette Syndrome (Raven Press, 1988)."},{"key":"742_CR36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpsychores.2009.09.002","volume":"67","author":"MH Bloch","year":"2009","unstructured":"Bloch, M. H. & Leckman, J. F. Clinical course of Tourette syndrome. J. Psychosom. Res. 67, 497\u2013501 (2009).","journal-title":"J. Psychosom. Res."},{"key":"742_CR37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaac.2017.01.010","volume":"56","author":"C Groth","year":"2017","unstructured":"Groth, C., Debes, N. M., Rask, C. U., Lange, T. & Skov, L. Course of Tourette syndrome and comorbidities in a large prospective clinical study. J. Am. Acad. Child Adolesc. Psychiatry 56, 304\u2013312 (2017).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"742_CR38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0733-8619(05)70313-3","volume":"15","author":"RD Bruun","year":"1997","unstructured":"Bruun, R. D. & Budman, C. L. The course and prognosis of Tourette syndrome. Neurol. Clin. 15, 291\u2013298 (1997).","journal-title":"Neurol. Clin."},{"key":"742_CR39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1542\/peds.110.2.331","volume":"110","author":"LA Snider","year":"2002","unstructured":"Snider, L. A. et al. Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 110, 331\u2013336 (2002).","journal-title":"Pediatrics"},{"key":"742_CR40","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1500766","volume":"16","author":"DT Noriega-Makarskyy","year":"2025","unstructured":"Noriega-Makarskyy, D. T. et al. Relationships between the menstrual cycle and neuropsychiatric and physical symptoms in females with Tourette syndrome. Front. Neurol. 16, 1500766 (2025).","journal-title":"Front. Neurol."},{"key":"742_CR41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.comppsych.2012.10.015","volume":"54","author":"T Steinberg","year":"2013","unstructured":"Steinberg, T., Shmuel-Baruch, S., Horesh, N. & Apter, A. Life events and Tourette syndrome. Compr. Psychiatry 54, 467\u2013473 (2013).","journal-title":"Compr. Psychiatry"},{"key":"742_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2024.152510","volume":"134","author":"SC Grossen","year":"2024","unstructured":"Grossen, S. C. et al. We\u2019ve all been wrong about provisional tic disorder. Compr. Psychiatry 134, 152510 (2024).","journal-title":"Compr. Psychiatry"},{"key":"742_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40133-4","volume":"9","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Provisional tic disorder is not so transient. Sci. Rep. 9, 3951 (2019).","journal-title":"Sci. Rep."},{"key":"742_CR44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpsychires.2020.12.040","volume":"133","author":"JF McGuire","year":"2021","unstructured":"McGuire, J. F. et al. Defining tic severity and tic impairment in Tourette disorder. J. Psychiatr. Res. 133, 93\u2013100 (2021).","journal-title":"J. Psychiatr. Res."},{"key":"742_CR45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.eurpsy.2014.07.003","volume":"30","author":"D Lichter","year":"2015","unstructured":"Lichter, D. & Finnegan, S. Influence of gender on Tourette syndrome beyond adolescence. Eur. Psychiatry 30, 334\u2013340 (2015).","journal-title":"Eur. Psychiatry"},{"key":"742_CR46","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.beth.2022.07.002","volume":"53","author":"EJ Ricketts","year":"2022","unstructured":"Ricketts, E. J. et al. Childhood predictors of long-term tic severity and tic impairment in Tourette\u2019s disorder. Behav. Ther. 53, 1250\u20131264 (2022).","journal-title":"Behav. Ther."},{"key":"742_CR47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpedi.160.1.65","volume":"160","author":"MH Bloch","year":"2006","unstructured":"Bloch, M. H. et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch. Pediatr. Adolesc. Med. 160, 65\u201369 (2006).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"742_CR48","volume":"7","author":"SM Schaefer","year":"2017","unstructured":"Schaefer, S. M., Chow, C. A., Louis, E. D. & Robakis, D. Tic exacerbation in adults with Tourette syndrome: a case series. Tremor Other Hyperkinetic Mov. 7, 450 (2017).","journal-title":"Tremor Other Hyperkinetic Mov."},{"key":"742_CR49","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/mds.23618","volume":"26","author":"J Jankovic","year":"2011","unstructured":"Jankovic, J. & Kurlan, R. Tourette syndrome: evolving concepts. Mov. Disord. 26, 1149\u20131156 (2011).","journal-title":"Mov. Disord."},{"key":"742_CR50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/mds.10180","volume":"17","author":"V Eapen","year":"2002","unstructured":"Eapen, V., Lees, A. J., Lakke, J., Trimble, M. R. & Robertson, M. M. Adult-onset tic disorders. Mov. Disord. 17, 735\u2013740 (2002).","journal-title":"Mov. Disord."},{"key":"742_CR51","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/mds.29454","volume":"38","author":"D Mataix-Cols","year":"2023","unstructured":"Mataix-Cols, D. et al. Early-life and family risk factors for tic disorder persistence into adulthood. Mov. Disord. 38, 1419\u20131427 (2023).","journal-title":"Mov. Disord."},{"key":"742_CR52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1469-7610.2005.01561.x","volume":"47","author":"MH Bloch","year":"2006","unstructured":"Bloch, M. H., Sukhodolsky, D. G., Leckman, J. F. & Schultz, R. T. Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette\u2019s syndrome. J. Child Psychol. Psychiatry 47, 551\u2013559 (2006).","journal-title":"J. Child Psychol. Psychiatry"},{"key":"742_CR53","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/archpsyc.61.12.1259","volume":"61","author":"R Marsh","year":"2004","unstructured":"Marsh, R. et al. Habit learning in Tourette syndrome: a translational neuroscience approach to a developmental psychopathology. Arch. Gen. Psychiatry 61, 1259\u20131268 (2004).","journal-title":"Arch. Gen. Psychiatry"},{"key":"742_CR54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00004583-200106000-00014","volume":"40","author":"BS Peterson","year":"2001","unstructured":"Peterson, B. S., Pine, D. S., Cohen, P. & Brook, J. S. Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit\/hyperactivity disorders in an epidemiological sample. J. Am. Acad. Child Adolesc. Psychiatry 40, 685\u2013695 (2001).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"742_CR55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajmg.b.32924","volume":"192","author":"M Abdulkadir","year":"2023","unstructured":"Abdulkadir, M., Tischfield, J. A., Heiman, G. A., Hoekstra, P. J. & Dietrich, A. Polygenic and environmental determinants of tics in the Avon Longitudinal Study of Parents and Children. Am. J. Med. Genet. B 192, 73\u201384 (2023).","journal-title":"Am. J. Med. Genet. B"},{"key":"742_CR56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.112.125468","volume":"204","author":"CA Mathews","year":"2014","unstructured":"Mathews, C. A. et al. Association between pre- and perinatal exposures and Tourette syndrome or chronic tic disorder in the ALSPAC cohort. Br. J. Psychiatry 204, 40\u201345 (2014).","journal-title":"Br. J. Psychiatry"},{"key":"742_CR57","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/mp.2017.31","volume":"23","author":"G Brander","year":"2018","unstructured":"Brander, G. et al. Perinatal risk factors in Tourette\u2019s and chronic tic disorders: a total population sibling comparison study. Mol. Psychiatry 23, 1189\u20131197 (2018).","journal-title":"Mol. Psychiatry"},{"key":"742_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01198-w","volume":"11","author":"VX Han","year":"2021","unstructured":"Han, V. X. et al. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Transl. Psychiatry 11, 71 (2021).","journal-title":"Transl. Psychiatry"},{"key":"742_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15496-z","volume":"23","author":"D Chen","year":"2023","unstructured":"Chen, D. et al. The correlation between prenatal maternal active smoking and neurodevelopmental disorders in children: a systematic review and meta-analysis. BMC Public Health 23, 611 https:\/\/doi.org\/10.1186\/s12889-023-15496-z (2023).","journal-title":"BMC Public Health"},{"key":"742_CR60","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.biopsych.2022.07.004","volume":"93","author":"T Zhang","year":"2023","unstructured":"Zhang, T. et al. Prenatal and early childhood infections and subsequent risk of obsessive-compulsive disorder and tic disorders: a nationwide, sibling-controlled study. Biol. Psychiatry 93, 1023\u20131030 https:\/\/doi.org\/10.1016\/j.biopsych.2022.07.004 (2023).","journal-title":"Biol. Psychiatry"},{"key":"742_CR61","volume":"11","author":"Y Chang","year":"2023","unstructured":"Chang, Y. et al. The correlation between tic disorders and allergic conditions in children: a systematic review and meta-analysis of observational studies. Front. Pediatrics 11, 1064001 (2023).","journal-title":"Front. Pediatrics"},{"key":"742_CR62","doi-asserted-by":"publisher","unstructured":"Fasching, L., Brady, M., Vaccarino, F. M., Singer, H. S. & Augustine, F. in Tourette Syndrome 2nd edn (eds Martino, D. & Leckman, J.) Ch. 14 https:\/\/doi.org\/10.1093\/med\/9780197543214.003.0015 (Oxford Univ. Press, 2022).","DOI":"10.1093\/med\/9780197543214.003.0015"},{"key":"742_CR63","first-page":"15","volume":"48","author":"HS Singer","year":"2025","unstructured":"Singer, H. S. & Pellicciotti, J. The pathophysiology of tics: an anatomic review. Psychiatr. Clin. 48, 15\u201329 (2025).","journal-title":"Psychiatr. Clin."},{"key":"742_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.psc.2024.09.004","volume":"48","author":"HS Singer","year":"2025","unstructured":"Singer, H. S. & Pellicciotti, J. The role of CBGTC synaptic neurotransmission in the pathophysiology of tics. Psychiatr. Clin. N. Am. 48, 203\u2013216 https:\/\/doi.org\/10.1016\/j.psc.2024.09.004 (2025).","journal-title":"Psychiatr. Clin. N. Am."},{"key":"742_CR65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tins.2006.01.001","volume":"29","author":"RL Albin","year":"2006","unstructured":"Albin, R. L. & Mink, J. W. Recent advances in Tourette syndrome research. Trends Neurosci. 29, 175\u2013182 (2006).","journal-title":"Trends Neurosci."},{"key":"742_CR66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005395","volume":"13","author":"D Caligiore","year":"2017","unstructured":"Caligiore, D., Mannella, F., Arbib, M. A. & Baldassarre, G. Dysfunctions of the basal ganglia-cerebellar-thalamo-cortical system produce motor tics in Tourette syndrome. PLoS Comput. Biol. 13, e1005395 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"742_CR67","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1523\/JNEUROSCI.0150-11.2011","volume":"31","author":"RJ Felling","year":"2011","unstructured":"Felling, R. J. & Singer, H. S. Neurobiology of Tourette syndrome: current status and need for further investigation. J. Neurosci. 31, 12387\u201312395 (2011).","journal-title":"J. Neurosci."},{"key":"742_CR68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1176\/appi.neuropsych.16070141","volume":"29","author":"AE Cavanna","year":"2017","unstructured":"Cavanna, A. E., Black, K. J., Hallett, M. & Voon, V. Neurobiology of the premonitory urge in Tourette\u2019s syndrome: pathophysiology and treatment implications. J. Neuropsychiatr. Clin. Neurosci. 29, 95\u2013104 (2017).","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"742_CR69","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/mds.26230","volume":"30","author":"S Tinaz","year":"2015","unstructured":"Tinaz, S., Malone, P., Hallett, M. & Horovitz, S. G. Role of the right dorsal anterior insula in the urge to tic in Tourette syndrome. Mov. Disord. 30, 1190\u20131197 (2015).","journal-title":"Mov. Disord."},{"key":"742_CR70","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/cne.22206","volume":"518","author":"Y Kataoka","year":"2010","unstructured":"Kataoka, Y. et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J. Comp. Neurol. 518, 277\u2013291 https:\/\/doi.org\/10.1002\/cne.22206 (2010).","journal-title":"J. Comp. Neurol."},{"key":"742_CR71","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.biopsych.2024.12.022","volume":"98","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Interneuron loss and microglia activation by transcriptome analyses in the basal ganglia of Tourette disorder. Biol. Psychiatry 98, 260\u2013270 https:\/\/doi.org\/10.1016\/j.biopsych.2024.12.022 (2025).","journal-title":"Biol. Psychiatry"},{"key":"742_CR72","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/brain\/awaa024","volume":"143","author":"V Rawji","year":"2020","unstructured":"Rawji, V. et al. Impaired automatic but intact volitional inhibition in primary tic disorders. Brain 143, 906\u2013919 https:\/\/doi.org\/10.1093\/brain\/awaa024 (2020).","journal-title":"Brain"},{"key":"742_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053156","volume":"11","author":"CK Kahl","year":"2021","unstructured":"Kahl, C. K. et al. Targeted Interventions in Tourette\u2019s using Advanced Neuroimaging and Stimulation (TITANS): study protocol for a double-blind, randomised controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area in children with Tourette\u2019s syndrome. BMJ Open 11 e053156 https:\/\/doi.org\/10.1136\/bmjopen-2021-053156 (2021).","journal-title":"BMJ Open"},{"key":"742_CR74","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4964","volume":"347","author":"AE Cavanna","year":"2013","unstructured":"Cavanna, A. E. & Seri, S. Tourette\u2019s syndrome. BMJ 347, f4964 (2013).","journal-title":"BMJ"},{"key":"742_CR75","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1176\/ajp.150.1.98","volume":"150","author":"JF Leckman","year":"1993","unstructured":"Leckman, J. F., Walker, D. E. & Cohen, D. J. Premonitory urges in Tourette\u2019s syndrome. Am. J. Psychiatry 150, 98\u2013102 (1993).","journal-title":"Am. J. Psychiatry"},{"key":"742_CR76","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cortex.2020.10.010","volume":"135","author":"T Bhikram","year":"2021","unstructured":"Bhikram, T., Crawley, A., Arnold, P., Abi-Jaoude, E. & Sandor, P. Neuroimaging the emotional modulation of urge inhibition in Tourette syndrome. Cortex 135, 341\u2013351 (2021).","journal-title":"Cortex"},{"key":"742_CR77","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s40474-015-0062-6","volume":"2","author":"DJ Greene","year":"2015","unstructured":"Greene, D. J., Schlaggar, B. L. & Black, K. J. Neuroimaging in Tourette syndrome: research highlights from 2014 to 2015. Curr. Dev. Disord. Rep. 2, 300\u2013308 (2015).","journal-title":"Curr. Dev. Disord. Rep."},{"key":"742_CR78","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archpsyc.58.5.427","volume":"58","author":"BS Peterson","year":"2001","unstructured":"Peterson, B. S. et al. Regional brain and ventricular volumes in Tourette syndrome. Arch. Gen. Psychiatry 58, 427\u2013440 (2001).","journal-title":"Arch. Gen. Psychiatry"},{"key":"742_CR79","volume":"2","author":"AC Williams","year":"2013","unstructured":"Williams, A. C. et al. A pilot study of basal ganglia and thalamus structure by high dimensional mapping in children with Tourette syndrome. F1000Research\u00a02, 207 (2013).","journal-title":"F1000Research"},{"key":"742_CR80","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1093\/brain\/awq293","volume":"133","author":"Y Worbe","year":"2010","unstructured":"Worbe, Y. et al. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Brain 133, 3649\u20133660 https:\/\/doi.org\/10.1093\/brain\/awq293 (2010).","journal-title":"Brain"},{"key":"742_CR81","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1523\/JNEUROSCI.3069-13.2014","volume":"34","author":"DJ Greene","year":"2014","unstructured":"Greene, D. J. et al. Developmental changes in the organization of functional connections between the basal ganglia and cerebral cortex. J. Neurosci. 34, 5842\u20135854 (2014).","journal-title":"J. Neurosci."},{"key":"742_CR82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17588928.2011.604717","volume":"2","author":"SR Jackson","year":"2011","unstructured":"Jackson, S. R., Parkinson, A., Kim, S. Y., Sch\u00fcermann, M. & Eickhoff, S. B. On the functional anatomy of the urge-for-action. Cognit. Neurosci. 2, 227\u2013243 (2011).","journal-title":"Cognit. Neurosci."},{"key":"742_CR83","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25614","volume":"5","author":"P Andr\u00e9n","year":"2022","unstructured":"Andr\u00e9n, P. et al. Therapist-supported internet-delivered exposure and response prevention for children and adolescents with Tourette syndrome: a randomized clinical trial. JAMA Netw. Open 5, e2225614 https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.25614 (2022).","journal-title":"JAMA Netw. Open"},{"key":"742_CR84","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.958688","volume":"13","author":"P Paschou","year":"2022","unstructured":"Paschou, P. et al. Enhancing Neuroimaging Genetics through Meta-analysis for Tourette Syndrome (ENIGMA-TS): a worldwide platform for collaboration. Front. Psychiatry 13, 958688 (2022).","journal-title":"Front. Psychiatry"},{"key":"742_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55242-6","volume":"15","author":"JC Baldermann","year":"2024","unstructured":"Baldermann, J. C. et al. A critical role of action-related functional networks in Gilles de la Tourette syndrome. Nat. Commun. 15, 10687 (2024).","journal-title":"Nat. Commun."},{"key":"742_CR86","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1093\/brain\/awac009","volume":"145","author":"C Ganos","year":"2022","unstructured":"Ganos, C. et al. A neural network for tics: insights from causal brain lesions and deep brain stimulation. Brain 145, 4385\u20134397 (2022).","journal-title":"Brain"},{"key":"742_CR87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-411546-0.00006-8","volume":"112","author":"P Paschou","year":"2013","unstructured":"Paschou, P., Fernandez, T. V., Sharp, F., Heiman, G. A. & Hoekstra, P. J. Genetic susceptibility and neurotransmitters in Tourette syndrome. Int. Rev. Neurobiol. 112, 155\u2013177 (2013).","journal-title":"Int. Rev. Neurobiol."},{"key":"742_CR88","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(02)11526-1","volume":"360","author":"JF Leckman","year":"2002","unstructured":"Leckman, J. F. Tourette\u2019s syndrome. Lancet 360, 1577\u20131586 (2002).","journal-title":"Lancet"},{"key":"742_CR89","doi-asserted-by":"crossref","DOI":"10.3390\/cells13141230","volume":"13","author":"RD Marshall","year":"2024","unstructured":"Marshall, R. D., Menniti, F. S. & Tepper, M. A. A novel PDE10A inhibitor for Tourette syndrome and other movement disorders. Cells 13, 1230 (2024).","journal-title":"Cells"},{"key":"742_CR90","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neubiorev.2012.10.004","volume":"37","author":"J Buse","year":"2013","unstructured":"Buse, J., Schoenefeld, K., M\u00fcnchau, A. & Roessner, V. Neuromodulation in Tourette syndrome: dopamine and beyond. Neurosci. Biobehav. Rev. 37, 1069\u20131084 (2013).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"742_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0202-y","volume":"8","author":"M Hienert","year":"2018","unstructured":"Hienert, M., Gryglewski, G., Stamenkovic, M., Kasper, S. & Lanzenberger, R. Striatal dopaminergic alterations in Tourette\u2019s syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies. Transl. Psychiatry 8, 143 (2018).","journal-title":"Transl. Psychiatry"},{"key":"742_CR92","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.biopsych.2018.02.1172","volume":"84","author":"TV Maia","year":"2018","unstructured":"Maia, T. V. & Concei\u00e7\u00e3o, V. A. Dopaminergic disturbances in Tourette syndrome: an integrative account. Biol. Psychiatry 84, 332\u2013344 (2018).","journal-title":"Biol. Psychiatry"},{"key":"742_CR93","unstructured":"Singer, H. S. in Tourette Syndrome 1st edn (eds Martino, D. & Leckman, J. F.) Ch. 13 (Oxford Univ. Press, 2013)."},{"key":"742_CR94","first-page":"1243","volume":"38","author":"DF Wong","year":"1997","unstructured":"Wong, D. F. et al. D2-like dopamine receptor density in Tourette syndrome measured by PET. J. Nucl. Med. 38, 1243\u20131247 (1997).","journal-title":"J. Nucl. Med."},{"key":"742_CR95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tins.2017.05.004","volume":"40","author":"M Rapanelli","year":"2017","unstructured":"Rapanelli, M., Frick, L. R. & Pittenger, C. The role of interneurons in autism and Tourette syndrome. Trends Neurosci. 40, 397\u2013407 (2017).","journal-title":"Trends Neurosci."},{"key":"742_CR96","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.cub.2014.08.038","volume":"24","author":"A Draper","year":"2014","unstructured":"Draper, A. et al. Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome. Curr. Biol. 24, 2343\u20132347 (2014).","journal-title":"Curr. Biol."},{"key":"742_CR97","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jamaneurol.2021.2798","volume":"78","author":"J Isung","year":"2021","unstructured":"Isung, J. et al. Association of Tourette syndrome and chronic tic disorder with cervical spine disorders and related neurological complications. JAMA Neurol. 78, 1205\u20131211 (2021).","journal-title":"JAMA Neurol."},{"key":"742_CR98","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mds.30084","volume":"40","author":"L Fern\u00e1ndez de la Cruz","year":"2025","unstructured":"Fern\u00e1ndez de la Cruz, L. et al. All-cause and cause-specific mortality in Tourette syndrome and chronic tic disorder. Mov. Disord. 40, 335\u2013344 (2025). This is an insightful population-based study documenting a broad number of preventable causes of death in individuals with tic disorders.","journal-title":"Mov. Disord."},{"key":"742_CR99","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa0907006","volume":"362","author":"AG Ercan-Sencicek","year":"2010","unstructured":"Ercan-Sencicek, A. G. et al. l-histidine decarboxylase and Tourette\u2019s syndrome. N. Engl. J. Med. 362, 1901\u20131908 (2010).","journal-title":"N. Engl. J. Med."},{"key":"742_CR100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/jmedgenet-2013-101637","volume":"50","author":"I Karagiannidis","year":"2013","unstructured":"Karagiannidis, I. et al. Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J. Med. Genet. 50, 760\u2013764 (2013).","journal-title":"J. Med. Genet."},{"key":"742_CR101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/brain\/aww285","volume":"140","author":"AS Kanaan","year":"2017","unstructured":"Kanaan, A. S. et al. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome. Brain 140, 218\u2013234 (2017).","journal-title":"Brain"},{"key":"742_CR102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003864","volume":"9","author":"LK Davis","year":"2013","unstructured":"Davis, L. K. et al. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet. 9, e1003864 (2013).","journal-title":"PLoS Genet."},{"key":"742_CR103","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1073\/pnas.1419533112","volume":"112","author":"M Xu","year":"2015","unstructured":"Xu, M. et al. Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome. Proc. Natl Acad. Sci. USA 112, 893\u2013898 https:\/\/doi.org\/10.1073\/pnas.1419533112 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"742_CR104","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuroscience.2016.02.074","volume":"324","author":"M Xu","year":"2016","unstructured":"Xu, M., Li, L. & Pittenger, C. Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming. Neuroscience 324, 321\u2013329 https:\/\/doi.org\/10.1016\/j.neuroscience.2016.02.074 (2016).","journal-title":"Neuroscience"},{"key":"742_CR105","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archpsyc.1985.01790310077011","volume":"42","author":"RA Price","year":"1985","unstructured":"Price, R. A., Kidd, K. K., Cohen, D. J., Pauls, D. L. & Leckman, J. F. A twin study of Tourette syndrome. Arch. Gen. Psychiatry 42, 815\u2013820 (1985).","journal-title":"Arch. Gen. Psychiatry"},{"key":"742_CR106","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamapsychiatry.2015.0627","volume":"72","author":"D Mataix-Cols","year":"2015","unstructured":"Mataix-Cols, D. et al. Familial risks of Tourette syndrome and chronic tic disorders: a population-based cohort study. JAMA Psychiatry 72, 787\u2013793 (2015).","journal-title":"JAMA Psychiatry"},{"key":"742_CR107","doi-asserted-by":"crossref","unstructured":"Jain, P., Paschou, P. & Topaloudi, A. in Handbook of Clinical Neurology Vol. 215: Tic Disorders and Tourette Syndrome (eds Ganos, C. & Worbe, Y.) 157\u2013167 (Elsevier, 2026).","DOI":"10.1016\/B978-0-443-13554-5.00020-1"},{"key":"742_CR108","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.neuron.2017.04.024","volume":"94","author":"AJ Willsey","year":"2017","unstructured":"Willsey, A. J. et al. De novo coding variants are strongly associated with Tourette disorder. Neuron 94, 486\u2013499.e9 (2017).","journal-title":"Neuron"},{"key":"742_CR109","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1176\/appi.ajp.2018.18070857","volume":"176","author":"D Yu","year":"2019","unstructured":"Yu, D. et al. Interrogating the genetic determinants of Tourette\u2019ssyndrome and other tic disorders through genome-wide association studies. Am. J. Psychiatry 176, 217\u2013227 https:\/\/doi.org\/10.1176\/appi.ajp.2018.18070857 (2019).","journal-title":"Am. J. Psychiatry"},{"key":"742_CR110","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1016\/j.celrep.2018.08.082","volume":"24","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. De novo sequence and copy number variants are strongly associated with Tourette disorder and implicate cell polarity in pathogenesis. Cell Rep. 24, 3441\u20133454.e12 (2018).","journal-title":"Cell Rep."},{"key":"742_CR111","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41586-025-09820-3","volume":"649","author":"AD Grotzinger","year":"2026","unstructured":"Grotzinger, A. D. et al. Mapping the genetic landscape across 14 psychiatric disorders. Nature 649, 406\u2013415 (2026).","journal-title":"Nature"},{"key":"742_CR112","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/mp.2012.69","volume":"18","author":"JM Scharf","year":"2013","unstructured":"Scharf, J. M. et al. Genome-wide association study of Tourette\u2019s syndrome. Mol. Psychiatry 18, 721\u2013728 (2013).","journal-title":"Mol. Psychiatry"},{"key":"742_CR113","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.biopsych.2023.01.023","volume":"96","author":"F Tsetsos","year":"2024","unstructured":"Tsetsos, F. et al. Genome-wide association study points to novel locus for Gilles de la Tourette syndrome. Biol. Psychiatry 96, 114\u2013124 (2024).","journal-title":"Biol. Psychiatry"},{"key":"742_CR114","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopsych.2020.12.028","volume":"90","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. Investigating shared genetic basis across Tourette syndrome and comorbid neurodevelopmental disorders along the impulsivity-compulsivity spectrum. Biol. Psychiatry 90, 317\u2013327 https:\/\/doi.org\/10.1016\/j.biopsych.2020.12.028 (2021).","journal-title":"Biol. Psychiatry"},{"key":"742_CR115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1176\/appi.ajp.2017.17030283","volume":"175","author":"PF Sullivan","year":"2018","unstructured":"Sullivan, P. F. et al. Psychiatric genomics: an update and an agenda. Am. J. Psychiatry 175, 15\u201327 (2018).","journal-title":"Am. J. Psychiatry"},{"key":"742_CR116","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.biopsych.2024.07.025","volume":"97","author":"NI Strom","year":"2025","unstructured":"Strom, N. I. et al. Genome-wide association study meta-analysis of 9619 cases with tic disorders. Biol. Psychiatry 97, 743\u2013752 (2025).","journal-title":"Biol. Psychiatry"},{"key":"742_CR117","doi-asserted-by":"publisher","unstructured":"Yu, D. et al. Genome-wide association analysis of tic disorders reveals 6 independent risk loci and highlights tic-associated cell types and brain circuitry. Preprint at medRxiv https:\/\/doi.org\/10.64898\/2026.04.09.26350245 (2026).","DOI":"10.64898\/2026.04.09.26350245"},{"key":"742_CR118","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-03056-x","volume":"42","author":"H Li","year":"2025","unstructured":"Li, H. et al. The dual role of PCDH9 in tumors, neurological and developmental diseases. Med. Oncol. 42, 489 https:\/\/doi.org\/10.1007\/s12032-025-03056-x (2025).","journal-title":"Med. Oncol."},{"key":"742_CR119","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.0491-24.2024","author":"F Miozzo","year":"2024","unstructured":"Miozzo, F. et al. Disruption of the autism-associated Pcdh9 gene leads to transcriptional alterations, synapse overgrowth, and defective network activity in the CA1. J. Neurosci. https:\/\/doi.org\/10.1523\/jneurosci.0491-24.2024 (2024).","journal-title":"J. Neurosci."},{"key":"742_CR120","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1093\/brain\/awy263","volume":"141","author":"C Marini","year":"2018","unstructured":"Marini, C. et al. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond. Brain 141, 3160\u20133178 https:\/\/doi.org\/10.1093\/brain\/awy263 (2018).","journal-title":"Brain"},{"key":"742_CR121","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biocel.2015.03.013","volume":"64","author":"G Chai","year":"2015","unstructured":"Chai, G., Goffinet, A. M. & Tissir, F. Celsr3 and Fzd3 in axon guidance. Int. J. Biochem. Cell Biol. 64, 11\u201314 https:\/\/doi.org\/10.1016\/j.biocel.2015.03.013 (2015).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"742_CR122","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nn1428","volume":"8","author":"F Tissir","year":"2005","unstructured":"Tissir, F., Bar, I., Jossin, Y., De Backer, O. & Goffinet, A. M. Protocadherin Celsr3 is crucial in axonal tract development. Nat. Neurosci. 8, 451\u2013457 https:\/\/doi.org\/10.1038\/nn1428 (2005).","journal-title":"Nat. Neurosci."},{"key":"742_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01082-z","volume":"11","author":"F Tsetsos","year":"2021","unstructured":"Tsetsos, F. et al. Synaptic processes and immune-related pathways implicated in Tourette syndrome. Transl. Psychiatry 11, 56 (2021).","journal-title":"Transl. Psychiatry"},{"key":"742_CR124","doi-asserted-by":"publisher","unstructured":"Wang, B. et al. Whole-exome sequencing in individuals with obsessive\u2013compulsive disorder and chronic tic disorders identifies 36 large-effect genes. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-026-02419-5 (2026).","DOI":"10.1038\/s41593-026-02419-5"},{"key":"742_CR125","doi-asserted-by":"publisher","unstructured":"Zhan, L. et al. Distinct patterns of de novo coding variants contribute to Tourette syndrome etiology. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.11.04.686570 (2025).","DOI":"10.1101\/2025.11.04.686570"},{"key":"742_CR126","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"742_CR127","doi-asserted-by":"publisher","unstructured":"Halvorsen, M. W. et al. Persistent tic disorders are associated with 17q12 duplications. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-026-03849-0 (2026).","DOI":"10.1038\/s41380-026-03849-0"},{"key":"742_CR128","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.neuron.2017.06.010","volume":"94","author":"AY Huang","year":"2017","unstructured":"Huang, A. Y. et al. Rare copy number variants in NRXN1 and CNTN6 increase risk for Tourette syndrome. Neuron 94, 1101\u20131111.e7 (2017).","journal-title":"Neuron"},{"key":"742_CR129","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1111\/ene.14983","volume":"28","author":"H Lamothe","year":"2021","unstructured":"Lamothe, H., Tamouza, R., Hartmann, A. & Mallet, L. Immunity and Gilles de la Tourette syndrome: a systematic review and meta-analysis of evidence for immune implications in Tourette syndrome. Eur. J. Neurol. 28, 3187\u20133200 (2021).","journal-title":"Eur. J. Neurol."},{"key":"742_CR130","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1212\/con.0000000000000752","volume":"25","author":"HS Singer","year":"2019","unstructured":"Singer, H. S. Tics and Tourette syndrome. Continuum 25, 936\u2013958 https:\/\/doi.org\/10.1212\/con.0000000000000752 (2019).","journal-title":"Continuum"},{"key":"742_CR131","doi-asserted-by":"publisher","DOI":"10.1017\/s003329172610419x","volume":"56","author":"J Pol-Fuster","year":"2026","unstructured":"Pol-Fuster, J. et al. Proneness to infections and familial risk of tic disorders. Psychol. Med. 56, e108 https:\/\/doi.org\/10.1017\/s003329172610419x (2026).","journal-title":"Psychol. Med."},{"key":"742_CR132","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbi.2020.12.035","volume":"94","author":"HF Jones","year":"2021","unstructured":"Jones, H. F. et al. Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: transcriptomic data show common enriched innate immune pathways. Brain Behav. Immun. 94, 308\u2013317 https:\/\/doi.org\/10.1016\/j.bbi.2020.12.035 (2021).","journal-title":"Brain Behav. Immun."},{"key":"742_CR133","first-page":"22","volume":"83","author":"S Mills","year":"2014","unstructured":"Mills, S. & Hedderly, T. A guide to childhood motor stereotypies, tic disorders and the Tourette spectrum for the primary care practitioner. Ulster Med. J. 83, 22\u201330 (2014).","journal-title":"Ulster Med. J."},{"key":"742_CR134","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMra010032","volume":"345","author":"J Jankovic","year":"2001","unstructured":"Jankovic, J. Tourette\u2019s syndrome. N. Engl. J. Med. 345, 1184\u20131192 https:\/\/doi.org\/10.1056\/NEJMra010032 (2001).","journal-title":"N. Engl. J. Med."},{"key":"742_CR135","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/s0387-7604(03)90004-0","volume":"25","author":"JF Leckman","year":"2003","unstructured":"Leckman, J. F. Phenomenology of tics and natural history of tic disorders. Brain Dev. 25, S24\u2013S28 https:\/\/doi.org\/10.1016\/s0387-7604(03)90004-0 (2003).","journal-title":"Brain Dev."},{"key":"742_CR136","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1469-8749.2000.tb00346.x","volume":"42","author":"RD Freeman","year":"2000","unstructured":"Freeman, R. D. et al. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev. Med. Child Neurol. 42, 436\u2013447 (2000).","journal-title":"Dev. Med. Child Neurol."},{"key":"742_CR137","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpsychores.2008.03.007","volume":"65","author":"MM Robertson","year":"2008","unstructured":"Robertson, M. M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes. J. Psychosom. Res. 65, 473\u2013486 (2008).","journal-title":"J. Psychosom. Res."},{"key":"742_CR138","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1192\/bjp.152.3.383","volume":"152","author":"MM Robertson","year":"1988","unstructured":"Robertson, M. M., Trimble, M. R. & Lees, A. J. The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis. Br. J. Psychiatry 152, 383\u2013390 (1988).","journal-title":"Br. J. Psychiatry"},{"key":"742_CR139","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jpsychires.2013.05.019","volume":"47","author":"CM Eddy","year":"2013","unstructured":"Eddy, C. M. & Cavanna, A. E. On being your own worst enemy: an investigation of socially inappropriate symptoms in Tourette syndrome. J. Psychiatr. Res. 47, 1259\u20131263 (2013).","journal-title":"J. Psychiatr. Res."},{"key":"742_CR140","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/mds.21599","volume":"22","author":"M.-Y.C. Cheung","year":"2007","unstructured":"Cheung, M.-Y.C., Shahed, J. & Jankovic, J. Malignant Tourette syndrome. Mov. Disord. 22, 1743\u20131750 https:\/\/doi.org\/10.1002\/mds.21599 (2007).","journal-title":"Mov. Disord."},{"key":"742_CR141","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mds.870060309","volume":"6","author":"J Jankovic","year":"1991","unstructured":"Jankovic, J. & Stone, L. Dystonic tics in patients with Tourette\u2019s syndrome. Mov. Disord. 6, 248\u2013252 (1991).","journal-title":"Mov. Disord."},{"key":"742_CR142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jnnp.47.1.1","volume":"47","author":"AJ Lees","year":"1984","unstructured":"Lees, A. J., Robertson, M., Trimble, M. R. & Murray, N. M. A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J. Neurol. Neurosurg. Psychiatry 47, 1\u20138 (1984).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"742_CR143","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/jnnp.2003.020693","volume":"75","author":"CA Mathews","year":"2004","unstructured":"Mathews, C. A. et al. Self injurious behaviour in Tourette syndrome: correlates with impulsivity and impulse control. J. Neurol. Neurosurg. Psychiatry 75, 1149\u20131155 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"742_CR144","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s00415-021-10822-0","volume":"269","author":"JF Baizabal-Carvallo","year":"2022","unstructured":"Baizabal-Carvallo, J. F., Alonso-Juarez, M. & Jankovic, J. Self-injurious behavior in Tourette syndrome. J. Neurol. 269, 2453\u20132459 https:\/\/doi.org\/10.1007\/s00415-021-10822-0 (2022).","journal-title":"J. Neurol."},{"key":"742_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00415","volume":"10","author":"T Sambrani","year":"2016","unstructured":"Sambrani, T., Jakubovski, E. & M\u00fcller-Vahl, K. R. New insights into clinical characteristics of Gilles de la Tourette syndrome: findings in 1032 patients from a single German center. Front. Neurosci. 10, 415 https:\/\/doi.org\/10.3389\/fnins.2016.00415 (2016).","journal-title":"Front. Neurosci."},{"key":"742_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105609","volume":"159","author":"JF Baizabal-Carvallo","year":"2024","unstructured":"Baizabal-Carvallo, J. F., Cavanna, A. E. & Jankovic, J. Tics emergencies and malignant Tourette syndrome: assessment and management. Neurosci. Biobehav. Rev. 159, 105609 https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105609 (2024).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"742_CR147","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s0733-8619(05)70311-x","volume":"15","author":"J Jankovic","year":"1997","unstructured":"Jankovic, J. Tourette syndrome. Phenomenology and classification of tics. Neurol. Clin. 15, 267\u2013275 https:\/\/doi.org\/10.1016\/s0733-8619(05)70311-x (1997).","journal-title":"Neurol. Clin."},{"key":"742_CR148","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/08830738060210081001","volume":"21","author":"JF Leckman","year":"2006","unstructured":"Leckman, J. F., Bloch, M. H., Scahill, L. & King, R. A. Tourette syndrome: the self under siege. J. Child Neurol. 21, 642\u2013649\u00a0(2006).","journal-title":"J. Child Neurol."},{"key":"742_CR149","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision: DSM-5-TR Ch. 6 (American Psychiatric Association, 2022).","DOI":"10.1176\/appi.books.9780890425787"},{"key":"742_CR150","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8428.1","volume":"5","author":"KJ Black","year":"2016","unstructured":"Black, K. J., Black, E. R., Greene, D. J. & Schlaggar, B. L. Provisional tic disorder: what to tell parents when their child first starts ticcing. F1000Research\u00a05, 696 https:\/\/doi.org\/10.12688\/f1000research.8428.1 (2016).","journal-title":"F1000Research"},{"key":"742_CR151","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1192\/bjp.187.3.262","volume":"187","author":"SL Hansson","year":"2005","unstructured":"Hansson, S. L. et al. Psychiatric telephone interview with parents for screening of childhood autism \u2014 tics, attention-deficit hyperactivity disorder and other comorbidities (A-TAC): preliminary reliability and validity. Br. J. Psychiatry 187, 262\u2013267 https:\/\/doi.org\/10.1192\/bjp.187.3.262 (2005).","journal-title":"Br. J. Psychiatry"},{"key":"742_CR152","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.26891","volume":"32","author":"D Martino","year":"2017","unstructured":"Martino, D. et al. Systematic review of severity scales and screening instruments for tics: critique and recommendations. Mov. Disord. 32, 467\u2013473 https:\/\/doi.org\/10.1002\/mds.26891 (2017). This paper summarizes the screening and severity scales used to assess tic disorders and describes their validity and reliability.","journal-title":"Mov. Disord."},{"key":"742_CR153","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.pcl.2015.03.007","volume":"62","author":"FJ Serajee","year":"2015","unstructured":"Serajee, F. J. & Mahbubul Huq, A. H. Advances in Tourette syndrome: diagnoses and treatment. Pediatr. Clin. North. Am. 62, 687\u2013701 https:\/\/doi.org\/10.1016\/j.pcl.2015.03.007 (2015).","journal-title":"Pediatr. Clin. North. Am."},{"key":"742_CR154","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/cap.1994.4.269","volume":"4","author":"GR Gaffney","year":"1994","unstructured":"Gaffney, G. R., Sieg, K. & Hellings, J. The MOVES: a self-rating scale for Tourette\u2019s syndrome. J. Child Adol Psychopharmacol. 4, 269\u2013280 (1994).","journal-title":"J. Child Adol Psychopharmacol."},{"key":"742_CR155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2466\/03.15.PR0.114k10w1","volume":"114","author":"T Larson","year":"2014","unstructured":"Larson, T. et al. Reliability of autism-tics, AD\/HD, and other comorbidities (A-TAC) inventory in a test-retest design. Psychol. Rep. 114, 93\u2013103 (2014).","journal-title":"Psychol. Rep."},{"key":"742_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-233","volume":"13","author":"T Larson","year":"2013","unstructured":"Larson, T. et al. Predictive properties of the A-TAC inventory when screening for childhood-onset neurodevelopmental problems in a population-based sample. BMC Psychiatry 13, 233 https:\/\/doi.org\/10.1186\/1471-244X-13-233 (2013).","journal-title":"BMC Psychiatry"},{"key":"742_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1504442","volume":"16","author":"JB Wohlgemuth","year":"2025","unstructured":"Wohlgemuth, J. B., Watson, K. H., Gill, K. D. & Isaacs, D. A. Premonitory urge in tic disorders \u2014 a scoping review. Front. Psychiatry 16, 1504442 https:\/\/doi.org\/10.3389\/fpsyt.2025.1504442 (2025).","journal-title":"Front. Psychiatry"},{"key":"742_CR158","unstructured":"Leckman, J. F., Towbin, K. E., Ort, S. I. & Cohen, D. J. in Tourette\u2019s Syndrome and Tic Disorders: Clinical Understanding and Treatment (eds Cohen, D. J. et al.) 56\u201378 (Wiley, 1988)."},{"key":"742_CR159","unstructured":"Shapiro, A. K., Shapiro, E. S., Young, J. G. & Feinberg, T. E. in Gilles de la Tourette Syndrome (eds Shapiro, A. K. et al.) 451\u2013480 (Raven Press, 1988)."},{"key":"742_CR160","first-page":"487","volume":"50","author":"H Duggal","year":"2002","unstructured":"Duggal, H. & Nizamie, S. H. Bereitschaftspotential in tic disorders: a preliminary observation. Neurol. India 50, 487\u2013489 (2002).","journal-title":"Neurol. India"},{"key":"742_CR161","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1073191103255497","volume":"10","author":"RD Shytle","year":"2003","unstructured":"Shytle, R. D. et al. The Tourette\u2019s Disorder Scale (TODS): development, reliability, and validity. Assessment 10, 273\u2013287 (2003).","journal-title":"Assessment"},{"key":"742_CR162","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10578-006-0043-4","volume":"38","author":"EA Storch","year":"2007","unstructured":"Storch, E. A. et al. Further psychometric examination of the Tourette\u2019s Disorder Scales. Child Psychiatry Hum. Dev. 38, 89\u201398 (2007).","journal-title":"Child Psychiatry Hum. Dev."},{"key":"742_CR163","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/1040-3590.17.4.486","volume":"17","author":"EA Storch","year":"2005","unstructured":"Storch, E. A. et al. Reliability and validity of the Yale Global Tic Severity Scale. Psychol. Assess. 17, 486\u2013491 (2005).","journal-title":"Psychol. Assess."},{"key":"742_CR164","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5334\/tohm.270","volume":"5","author":"K Kompoliti","year":"2016","unstructured":"Kompoliti, K. Sources of disability in Tourette syndrome: children vs. adults. Tremor Other Hyperkinetic Mov. 5, 318\u2013318 (2016).","journal-title":"Tremor Other Hyperkinetic Mov."},{"key":"742_CR165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/07317100903099100","volume":"31","author":"S Chang","year":"2009","unstructured":"Chang, S., Himle, M. B., Tucker, B. T. P., Woods, D. W. & Piacentini, J. Initial psychometic properties of a brief parent-report instrument for assessing tic severity in children with chronic tic disorders. Child Fam. Behav. Ther. 31, 181\u2013191 (2009).","journal-title":"Child Fam. Behav. Ther."},{"key":"742_CR166","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.beth.2015.06.002","volume":"46","author":"A Abramovitch","year":"2015","unstructured":"Abramovitch, A. et al. Psychometric properties of a self-report instrument for the assessment of tic severity in adults with tic disorders. Behav. Ther. 46, 786\u2013796 https:\/\/doi.org\/10.1016\/j.beth.2015.06.002 (2015).","journal-title":"Behav. Ther."},{"key":"742_CR167","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s00415-012-6470-1","volume":"259","author":"D Martino","year":"2012","unstructured":"Martino, D., Cavanna, A. E., Robertson, M. M. & Orth, M. Prevalence and phenomenology of eye tics in Gilles de la Tourette syndrome. J. Neurol. 259, 2137\u20132140 https:\/\/doi.org\/10.1007\/s00415-012-6470-1 (2012).","journal-title":"J. Neurol."},{"key":"742_CR168","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.102.1.14","volume":"102","author":"JF Leckman","year":"1998","unstructured":"Leckman, J. F. et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 102, 14\u201319 (1998).","journal-title":"Pediatrics"},{"key":"742_CR169","doi-asserted-by":"crossref","unstructured":"Singer, H. S., Mink, J. W., Gilbert, D. L. & Jankovic, J. Movement Disorders in Childhood 3rd edn, Ch. 7 (Elsevier, 2022).","DOI":"10.1016\/B978-0-12-820552-5.00023-1"},{"key":"742_CR170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2026.01.010","volume":"177","author":"HS Singer","year":"2026","unstructured":"Singer, H. S., Mills, C. C., Pellicciotti, J. & Mahone, E. M. Reconsidering the clinical outcome, effect of sex, and diagnostic criterion of primary complex motor stereotypies in children. Pediatr. Neurol. 177, 62\u201367 (2026).","journal-title":"Pediatr. Neurol."},{"key":"742_CR171","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.pediatrneurol.2007.12.008","volume":"38","author":"KM Harris","year":"2008","unstructured":"Harris, K. M., Mahone, E. M. & Singer, H. S. Nonautistic motor stereotypies: clinical features and longitudinal follow-up. Pediatr. Neurol. 38, 267\u2013272 https:\/\/doi.org\/10.1016\/j.pediatrneurol.2007.12.008 (2008).","journal-title":"Pediatr. Neurol."},{"key":"742_CR172","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jamapsychiatry.2014.2650","volume":"72","author":"ME Hirschtritt","year":"2015","unstructured":"Hirschtritt, M. E. et al. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry 72, 325\u2013333 (2015). This paper describes the frequency and developmental timing of the most common psychiatric comorbidities in TS.","journal-title":"JAMA Psychiatry"},{"key":"742_CR173","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1017\/s0033291717001672","volume":"48","author":"ME Hirschtritt","year":"2018","unstructured":"Hirschtritt, M. E. et al. Genetic and phenotypic overlap of specific obsessive-compulsive and attention-deficit\/hyperactive subtypes with Tourette syndrome. Psychol. Med. 48, 279\u2013293 https:\/\/doi.org\/10.1017\/s0033291717001672 (2018).","journal-title":"Psychol. Med."},{"key":"742_CR174","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1176\/appi.ajp.2016.16020240","volume":"174","author":"SM Darrow","year":"2017","unstructured":"Darrow, S. M. et al. Identification of two heritable cross-disorder endophenotypes for Tourette syndrome. Am. J. Psychiatry 174, 387\u2013396 https:\/\/doi.org\/10.1176\/appi.ajp.2016.16020240 (2017).","journal-title":"Am. J. Psychiatry"},{"key":"742_CR175","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1192\/bjp.162.5.593","volume":"162","author":"V Eapen","year":"1993","unstructured":"Eapen, V., Pauls, D. L. & Robertson, M. M. Evidence for autosomal dominant transmission in Tourette\u2019s syndrome. United Kingdom cohort study. Br. J. Psychiatry 162, 593\u2013596 (1993).","journal-title":"Br. J. Psychiatry"},{"key":"742_CR176","doi-asserted-by":"publisher","DOI":"10.7916\/D8VM4B13","volume":"5","author":"JF Baizabal-Carvallo","year":"2015","unstructured":"Baizabal-Carvallo, J. F. & Fekete, R. Recognizing uncommon presentations of psychogenic (functional) movement disorders. Tremor Other Hyperkinetic Mov. 5, 279 https:\/\/doi.org\/10.7916\/D8VM4B13 (2015).","journal-title":"Tremor Other Hyperkinetic Mov."},{"key":"742_CR177","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/mds.22114","volume":"24","author":"S Ertan","year":"2009","unstructured":"Ertan, S. et al. Clinical characteristics of 49 patients with psychogenic movement disorders in a tertiary clinic in Turkey. Mov. Disord. 24, 759\u2013762 https:\/\/doi.org\/10.1002\/mds.22114 (2009).","journal-title":"Mov. Disord."},{"key":"742_CR178","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jpsychires.2024.07.011","volume":"177","author":"K Hartung","year":"2024","unstructured":"Hartung, K. et al. Prevalence of mass social media-induced illness presenting with Tourette-like behavior in Germany between 2019 and 2021. J. Psychiatr. Res. 177, 234\u2013238 https:\/\/doi.org\/10.1016\/j.jpsychires.2024.07.011 (2024).","journal-title":"J. Psychiatr. Res."},{"key":"742_CR179","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/nyas.12298","volume":"1304","author":"JW Mink","year":"2013","unstructured":"Mink, J. W. Conversion disorder and mass psychogenic illness in child neurology. Ann. N. Y. Acad. Sci. 1304, 40\u201344 https:\/\/doi.org\/10.1111\/nyas.12298 (2013).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"742_CR180","first-page":"144","volume":"31","author":"G Amorelli","year":"2022","unstructured":"Amorelli, G., Martino, D. & Pringsheim, T. Rapid onset functional tic-like disorder outbreak: a challenging differential diagnosis in the COVID-19 pandemic. J. Can. Acad. Child Adolesc. Psychiatry 31, 144\u2013151 (2022).","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"key":"742_CR181","doi-asserted-by":"publisher","first-page":"863919","DOI":"10.3389\/fped.2022.863919","volume":"10","author":"JM Martindale","year":"2022","unstructured":"Martindale, J. M. & Mink, J. W. The rise of functional tic-like behaviors: what do the COVID-19 pandemic and social media have to do with it? A narrative review. Front. Pediatr. 10, 863919 https:\/\/doi.org\/10.3389\/fped.2022.863919 (2022).","journal-title":"Front. Pediatr."},{"key":"742_CR182","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/mdc3.13316","volume":"8","author":"C Olvera","year":"2021","unstructured":"Olvera, C., Stebbins, G. T., Goetz, C. G. & Kompoliti, K. TikTok tics: a pandemic within a pandemic. Mov. Disord. Clin. Pract. 8, 1200\u20131205 https:\/\/doi.org\/10.1002\/mdc3.13316 (2021).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR183","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/mds.28778","volume":"36","author":"T Pringsheim","year":"2021","unstructured":"Pringsheim, T. et al. Rapid onset functional tic-like behaviors in young females during the COVID-19 pandemic. Mov. Disord. 36, 2707\u20132713 https:\/\/doi.org\/10.1002\/mds.28778 (2021).","journal-title":"Mov. Disord."},{"key":"742_CR184","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/ene.15611","volume":"30","author":"D Martino","year":"2023","unstructured":"Martino, D. et al. The spectrum of functional tic-like behaviours: data from an international registry. Eur. J. Neurol. 30, 334\u2013343 https:\/\/doi.org\/10.1111\/ene.15611 (2023).","journal-title":"Eur. J. Neurol."},{"key":"742_CR185","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.129252.2","volume":"11","author":"AL Arbuckle","year":"2022","unstructured":"Arbuckle, A. L., Bihun, E. C., Schlaggar, B. L. & Black, K. J. Functional tic-like presentations differ strikingly from provisional tic disorder. F1000Research 11, 1566 https:\/\/doi.org\/10.12688\/f1000research.129252.2 (2022). This paper compares and contrasts the presentation of TS and functional tic disorders.","journal-title":"F1000Research"},{"key":"742_CR186","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00406-023-01603-z","volume":"274","author":"C Fremer","year":"2024","unstructured":"Fremer, C. et al. What distinguishes patients with mass social media-induced illness presenting with Tourette-like behavior from those with Tourette syndrome? Results of a prospective cohort study. Eur. Arch. Psychiatry Clin. Neurosci. 274, 227\u2013233 https:\/\/doi.org\/10.1007\/s00406-023-01603-z (2024).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"742_CR187","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/jcm14051485","volume":"14","author":"S Gunturu","year":"2025","unstructured":"Gunturu, S. et al. Unpacking Tourette syndrome in children: insights into prevalence and comorbidities from NSCH data. J. Clin. Med. 14, 1485 https:\/\/doi.org\/10.3390\/jcm14051485 (2025).","journal-title":"J. Clin. Med."},{"key":"742_CR188","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41398-024-03011-w","volume":"14","author":"TW Miller-Fleming","year":"2024","unstructured":"Miller-Fleming, T. W. et al. Developing a phenotype risk score for tic disorders in a large, clinical biobank. Transl. Psychiatry 14, 311 https:\/\/doi.org\/10.1038\/s41398-024-03011-w (2024).","journal-title":"Transl. Psychiatry"},{"key":"742_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2016.00097","volume":"7","author":"V Eapen","year":"2016","unstructured":"Eapen, V., Cavanna, A. E. & Robertson, M. M. Comorbidities, social impact, and quality of life in Tourette syndrome. Front. Psychiatry 7, 97 https:\/\/doi.org\/10.3389\/fpsyt.2016.00097 (2016).","journal-title":"Front. Psychiatry"},{"key":"742_CR190","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/mds.23434","volume":"26","author":"CM Eddy","year":"2011","unstructured":"Eddy, C. M. et al. Clinical correlates of quality of life in Tourette syndrome. Mov. Disord. 26, 735\u2013738 https:\/\/doi.org\/10.1002\/mds.23434 (2011).","journal-title":"Mov. Disord."},{"key":"742_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-017-0196-x","volume":"11","author":"E Cravedi","year":"2017","unstructured":"Cravedi, E. et al. Tourette syndrome and other neurodevelopmental disorders: a comprehensive review. Child Adolesc. Psychiatry Ment. Health 11, 59 https:\/\/doi.org\/10.1186\/s13034-017-0196-x (2017).","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"key":"742_CR192","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/088307380101600609","volume":"16","author":"L Burd","year":"2001","unstructured":"Burd, L. et al. Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome. J. Child Neurol. 16, 431\u2013437 (2001).","journal-title":"J. Child Neurol."},{"key":"742_CR193","volume":"65","author":"C Groth","year":"2018","unstructured":"Groth, C. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors. Dan. Med. J. 65, B5465 (2018).","journal-title":"Dan. Med. J."},{"key":"742_CR194","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mds.28842","volume":"37","author":"K Isomura","year":"2022","unstructured":"Isomura, K. et al. Insomnia in Tourette syndrome and chronic tic disorder. Mov. Disord. 37, 392\u2013400 (2022).","journal-title":"Mov. Disord."},{"key":"742_CR195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.biopsych.2020.09.014","volume":"89","author":"S Virtanen","year":"2021","unstructured":"Virtanen, S. et al. Association of Tourette syndrome and chronic tic disorder with subsequent risk of alcohol-or drug-related disorders, criminal convictions, and death: a population-based family study. Biol. Psychiatry 89, 407\u2013414 (2021).","journal-title":"Biol. Psychiatry"},{"key":"742_CR196","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/mds.70036","volume":"40","author":"N Razaz","year":"2025","unstructured":"Razaz, N. & Fern\u00e1ndez de la Cruz, L. Pregnancy, delivery, and neonatal outcomes in women with Tourette syndrome or chronic tic disorder. Mov. Disord. 40, 2830\u20132835 (2025).","journal-title":"Mov. Disord."},{"key":"742_CR197","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0000000000007466","volume":"92","author":"T Pringsheim","year":"2019","unstructured":"Pringsheim, T. et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92, 896\u2013906 (2019). This is an important publication on international guidelines for the treatment of TS.","journal-title":"Neurology"},{"key":"742_CR198","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00787-021-01832-4","volume":"31","author":"KR M\u00fcller-Vahl","year":"2022","unstructured":"M\u00fcller-Vahl, K. R. et al. European clinical guidelines for Tourette syndrome and other tic disorders: summary statement. Eur. Child Adolesc. Psychiatry 31, 377\u2013382 https:\/\/doi.org\/10.1007\/s00787-021-01832-4 (2022).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"742_CR199","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00787-021-01899-z","volume":"31","author":"V Roessner","year":"2022","unstructured":"Roessner, V. et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur. Child Adolesc. Psychiatry 31, 425\u2013441 https:\/\/doi.org\/10.1007\/s00787-021-01899-z (2022).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"742_CR200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/070674371205700302","volume":"57","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim, T. et al. Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can. J. Psychiatry 57, 133\u2013143 (2012).","journal-title":"Can. J. Psychiatry"},{"key":"742_CR201","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/070674371205700303","volume":"57","author":"T Steeves","year":"2012","unstructured":"Steeves, T. et al. Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can. J. Psychiatry 57, 144\u2013151 (2012).","journal-title":"Can. J. Psychiatry"},{"key":"742_CR202","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.psc.2024.08.008","volume":"48","author":"BO Jurgen","year":"2025","unstructured":"Jurgen, B. O. & Greenberg, E. L. Pharmacotherapy for Tourette syndrome. Psychiatr. Clin. N. Am. 48, 91\u2013107 https:\/\/doi.org\/10.1016\/j.psc.2024.08.008 (2025).","journal-title":"Psychiatr. Clin. N. Am."},{"key":"742_CR203","doi-asserted-by":"crossref","unstructured":"Rizzo, R. in Handbook of Clinical Neurology Vol. 215: Tic Disorders and Tourette Syndrome (eds Ganos, C. & Worbe, Y.) 273\u2013281 (Elsevier, 2026).","DOI":"10.1016\/B978-0-443-13554-5.00029-8"},{"key":"742_CR204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14656566.2026.2629472","volume":"27","author":"AE Cavanna","year":"2026","unstructured":"Cavanna, A. E. When is pharmacotherapy necessary for Tourette syndrome? The risks vs reward. Expert Opin. Pharmacother. 27, 21\u201325 (2026).","journal-title":"Expert Opin. Pharmacother."},{"key":"742_CR205","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mds.29714","volume":"39","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Placebo and nocebo responses in pharmacological trials of tic disorders: a meta-analysis. Mov. Disord. 39, 585\u2013595 (2024).","journal-title":"Mov. Disord."},{"key":"742_CR206","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/ijnp\/pyab054","volume":"25","author":"X Castells","year":"2022","unstructured":"Castells, X. et al. Placebo response and its predictors in attention deficit hyperactivity disorder: a meta-analysis and comparison of meta-regression and MetaForest. Int. J. Neuropsychopharmacol. 25, 26\u201335 (2022).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"742_CR207","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/1570159X16666181026163922","volume":"17","author":"GD Kotzalidis","year":"2019","unstructured":"Kotzalidis, G. D. et al. Placebo effect in obsessive-compulsive disorder (OCD). Placebo response and placebo responders in OCD: the trend over time. Curr. Neuropharmacol. 17, 741\u2013774 (2019).","journal-title":"Curr. Neuropharmacol."},{"key":"742_CR208","doi-asserted-by":"crossref","unstructured":"Abi-Jaoude, E., Gorman, D. A. & Sandor, P.\u00a0in Handbook of Clinical Neurology Vol. 215: Tic Disorders and Tourette Syndrome (eds Ganos, C. & Worbe, Y.) 311\u2013326 (Elsevier, 2026).","DOI":"10.1016\/B978-0-443-13554-5.00008-0"},{"key":"742_CR209","doi-asserted-by":"crossref","unstructured":"Brandt, V., Perroud, N. A. & Plessen, K. J. in Handbook of Clinical Neurology Vol. 215: Tic Disorders and Tourette Syndrome (eds Ganos, C. & Worbe, Y.)\u00a085\u201396 (Elsevier, 2026).","DOI":"10.1016\/B978-0-443-13554-5.00003-1"},{"key":"742_CR210","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.psc.2024.08.007","volume":"48","author":"H Katato","year":"2025","unstructured":"Katato, H., Muniz, J. A., Lopez-Arvizu, C. & McGuire, J. F. Evidence-based behavior therapy for Tourette syndrome. Psychiatr. Clin. N. Am. 48, 77\u201389 https:\/\/doi.org\/10.1016\/j.psc.2024.08.007 (2025).","journal-title":"Psychiatr. Clin. N. Am."},{"key":"742_CR211","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","volume":"52","author":"TK Murphy","year":"2013","unstructured":"Murphy, T. K., Lewin, A. B., Storch, E. A. & Stock, S. Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J. Am. Acad. Child Adolesc. Psychiatry 52, 1341\u20131359 https:\/\/doi.org\/10.1016\/j.jaac.2013.09.015 (2013).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"742_CR212","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70464","author":"T Pringsheim","year":"2025","unstructured":"Pringsheim, T. et al. Complementary and integrative medicine for the treatment of Tourette\u2019s syndrome. Mov. Disord. Clin. Pract. https:\/\/doi.org\/10.1002\/mdc3.70464 (2025).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR213","doi-asserted-by":"crossref","unstructured":"Himle, M. B., Marklin, M. & Wellen, B. in Handbook of Clinical Neurology Vol. 215: Tic Disorders and Tourette Syndrome (eds Ganos, C. & Worbe, Y.) 263\u2013271 (Elsevier, 2026).","DOI":"10.1016\/B978-0-443-13554-5.00030-4"},{"key":"742_CR214","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/cap.2024.0023","volume":"35","author":"K Kohler","year":"2025","unstructured":"Kohler, K., Rosen, N. & Piacentini, J. Description, implementation, and efficacy of the comprehensive behavioral intervention for tics as first-line treatment for Tourette and other tic disorders. J. Child Adolesc. Psychopharmacol. 35, 126\u2013134 (2025).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"742_CR215","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0005-7967(73)90119-8","volume":"11","author":"N Azrin","year":"1973","unstructured":"Azrin, N. & Nunn, R. Habit-reversal: a method of eliminating nervous habits and tics. Behav. Res. Ther. 11, 619\u2013628 (1973).","journal-title":"Behav. Res. Ther."},{"key":"742_CR216","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.2010.607","volume":"303","author":"J Piacentini","year":"2010","unstructured":"Piacentini, J. et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 303, 1929\u20131937 (2010).","journal-title":"JAMA"},{"key":"742_CR217","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archgenpsychiatry.2011.1528","volume":"69","author":"S Wilhelm","year":"2012","unstructured":"Wilhelm, S. et al. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch. Gen. Psychiatry 69, 795\u2013803 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"742_CR218","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10578-021-01178-7","volume":"53","author":"SM Bennett","year":"2022","unstructured":"Bennett, S. M. et al. Proof of concept study of an oral orthotic in reducing tic severity in Tourette syndrome. Child Psychiatry Hum. Dev. 53, 953\u2013963 (2022).","journal-title":"Child Psychiatry Hum. Dev."},{"key":"742_CR219","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00100","volume":"9","author":"R Rizzo","year":"2018","unstructured":"Rizzo, R., Pellico, A., Silvestri, P. R., Chiarotti, F. & Cardona, F. A randomized controlled trial comparing behavioral, educational, and pharmacological treatments in youths with chronic tic disorder or Tourette syndrome. Front. Psychiatry 9, 100 (2018).","journal-title":"Front. Psychiatry"},{"key":"742_CR220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jpsychires.2013.12.009","volume":"50","author":"JF McGuire","year":"2014","unstructured":"McGuire, J. F. et al. A meta-analysis of behavior therapy for Tourette syndrome. J. Psychiatr. Res. 50, 106\u2013112 (2014).","journal-title":"J. Psychiatr. Res."},{"key":"742_CR221","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-021-00362-w","volume":"15","author":"J Nissen","year":"2021","unstructured":"Nissen, J., Carlsen, A. & Thomsen, P. One-year outcome of manualised behavior therapy of chronic tic disorders in children and adolescents. Child Adolesc. Psychiatry Ment. Health 15, 9 (2021).","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"key":"742_CR222","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024685","volume":"9","author":"P Andr\u00e9n","year":"2019","unstructured":"Andr\u00e9n, P. et al. Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette\u2019s disorder: a pilot randomised controlled trial with long-term follow-up. BMJ Open 9, e024685 (2019).","journal-title":"BMJ Open"},{"key":"742_CR223","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.8468","volume":"7","author":"P Andr\u00e9n","year":"2024","unstructured":"Andr\u00e9n, P. et al. Internet-delivered exposure and response prevention for pediatric tourette syndrome: 12-month follow-up of a randomized clinical trial. JAMA Netw. Open 7, e248468 (2024).","journal-title":"JAMA Netw. Open"},{"key":"742_CR224","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/jcpp.13756","volume":"64","author":"C Hollis","year":"2023","unstructured":"Hollis, C. et al. Long-term clinical and cost-effectiveness of a therapist-supported online remote behavioural intervention for tics in children and adolescents: extended 12- and 18-month follow-up of a single-blind randomised controlled trial. J. Child Psychol. Psychiatry 64, 941\u2013951 https:\/\/doi.org\/10.1111\/jcpp.13756 (2023).","journal-title":"J. Child Psychol. Psychiatry"},{"key":"742_CR225","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","volume":"37","author":"H Weisman","year":"2013","unstructured":"Weisman, H., Qureshi, I. A., Leckman, J. F., Scahill, L. & Bloch, M. H. Systematic review: pharmacological treatment of tic disorders \u2014 efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci. Biobehav. Rev. 37, 1162\u20131171 https:\/\/doi.org\/10.1016\/j.neubiorev.2012.09.008 (2013).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"742_CR226","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.neurol.2024.04.005","volume":"180","author":"A Hartmann","year":"2024","unstructured":"Hartmann, A. et al. French guidelines for the diagnosis and management of Tourette syndrome. Rev. Neurol. 180, 818\u2013827 https:\/\/doi.org\/10.1016\/j.neurol.2024.04.005 (2024). This article presents recent guidelines on the diagnosis and management of TS.","journal-title":"Rev. Neurol."},{"key":"742_CR227","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/14656566.2020.1721465","volume":"21","author":"N Cothros","year":"2020","unstructured":"Cothros, N., Medina, A. & Pringsheim, T. Current pharmacotherapy for tic disorders. Expert Opin. Pharmacother. 21, 567\u2013580 https:\/\/doi.org\/10.1080\/14656566.2020.1721465 (2020).","journal-title":"Expert Opin. Pharmacother."},{"key":"742_CR228","doi-asserted-by":"publisher","unstructured":"Hollis, C. et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis. Health Technol. Assess.\u00a0https:\/\/doi.org\/10.3310\/hta20040 (2016).","DOI":"10.3310\/hta20040"},{"key":"742_CR229","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s13760-025-02864-2","volume":"126","author":"MA Muneer","year":"2025","unstructured":"Muneer, M. A. et al. Efficacy of aripiprazole and valbenazine in the treatment of Tourette syndrome: a systematic review and meta-analysis of randomized controlled trials. Acta Neurol. Belg. 126, 747\u2013756 (2025).","journal-title":"Acta Neurol. Belg."},{"key":"742_CR230","volume":"98","author":"C Yang","year":"2019","unstructured":"Yang, C., Yi, Q., Zhang, L., Cui, H. & Mao, J. Safety of aripiprazole for tics in children and adolescents: a systematic review and meta-analysis. Medicine 98, e15816 (2019).","journal-title":"Medicine"},{"key":"742_CR231","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00002826-200211000-00009","volume":"25","author":"DD Cummings","year":"2002","unstructured":"Cummings, D. D., Singer, H. S., Krieger, M., Miller, T. L. & Mahone, E. M. Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin. Neuropharmacol. 25, 325\u2013332 https:\/\/doi.org\/10.1097\/00002826-200211000-00009 (2002).","journal-title":"Clin. Neuropharmacol."},{"key":"742_CR232","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1089\/cap.2017.0024","volume":"27","author":"TK Murphy","year":"2017","unstructured":"Murphy, T. K. et al. Extended-release guanfacine does not show a large effect on tic severity in children with chronic tic disorders. J. Child Adolesc. Psychopharmacol. 27, 762\u2013770 https:\/\/doi.org\/10.1089\/cap.2017.0024 (2017).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"742_CR233","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","volume":"158","author":"L Scahill","year":"2001","unstructured":"Scahill, L. et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am. J. Psychiatry 158, 1067\u20131074 https:\/\/doi.org\/10.1176\/appi.ajp.158.7.1067 (2001).","journal-title":"Am. J. Psychiatry"},{"key":"742_CR234","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.pediatrneurol.2013.05.002","volume":"49","author":"CS Yang","year":"2013","unstructured":"Yang, C.-S., Zhang, L.-L., Zeng, L.-N., Huang, L. & Liu, Y.-T. Topiramate for Tourette\u2019s syndrome in children: a meta-analysis. Pediatr. Neurol. 49, 344\u2013350 https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.05.002 (2013).","journal-title":"Pediatr. Neurol."},{"key":"742_CR235","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1089\/cap.2019.0161","volume":"30","author":"L Yu","year":"2020","unstructured":"Yu, L. et al. Revisiting the efficacy and tolerability of topiramate for tic disorders: a meta-analysis. J. Child Adolesc. Psychopharmacol. 30, 316\u2013325 (2020).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"742_CR236","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/088307389901400508","volume":"14","author":"Y Awaad","year":"1999","unstructured":"Awaad, Y. Tics in Tourette syndrome: new treatment options. J. Child Neurol. 14, 316\u2013319 (1999).","journal-title":"J. Child Neurol."},{"key":"742_CR237","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1212\/wnl.56.5.599","volume":"56","author":"HS Singer","year":"2001","unstructured":"Singer, H. S., Wendlandt, J., Krieger, M. & Giuliano, J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology 56, 599\u2013604 https:\/\/doi.org\/10.1212\/wnl.56.5.599 (2001).","journal-title":"Neurology"},{"key":"742_CR238","first-page":"245","volume":"58","author":"C Goetz","year":"1992","unstructured":"Goetz, C. Clonidine and clonazepam in Tourette syndrome. Adv. Neurol. 58, 245\u2013251 (1992).","journal-title":"Adv. Neurol."},{"key":"742_CR239","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0447.1985.tb02628.x","volume":"72","author":"JR Merikangas","year":"1985","unstructured":"Merikangas, J. R., Merikangas, K., Kopp, U. & Hanin, I. Blood choline and response to clonazepam and haloperidol in Tourette\u2019s syndrome. Acta Psychiatr. Scand. 72, 395\u2013399 (1985).","journal-title":"Acta Psychiatr. Scand."},{"key":"742_CR240","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40263-017-0486-0","volume":"32","author":"J Quezada","year":"2018","unstructured":"Quezada, J. & Coffman, K. A. Current approaches and new developments in the pharmacological management of Tourette syndrome. CNS Drugs 32, 33\u201345 https:\/\/doi.org\/10.1007\/s40263-017-0486-0 (2018).","journal-title":"CNS Drugs"},{"key":"742_CR241","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00115-006-2131-x","volume":"78","author":"K M\u00fcller-Vahl","year":"2007","unstructured":"M\u00fcller-Vahl, K. Die benzamide tiaprid, sulpirid und amisulprid in der therapie des Tourette-syndroms. Der Nervenarzt 78, 264\u2013271 (2007).","journal-title":"Der Nervenarzt"},{"key":"742_CR242","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1021\/acschemneuro.7b00460","volume":"9","author":"S Mogwitz","year":"2018","unstructured":"Mogwitz, S., Buse, J., Wolff, N. & Roessner, V. Update on the pharmacological treatment of tics with dopamine-modulating agnts. ACS Chem. Neurosci. 9, 651\u2013672 https:\/\/doi.org\/10.1021\/acschemneuro.7b00460 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"742_CR243","volume":"11","author":"Z-S Liu","year":"2020","unstructured":"Liu, Z.-S. et al. Current status, diagnosis, and treatment recommendation for tic disorders in China. Front. Psychiatry 11, 774 (2020).","journal-title":"Front. Psychiatry"},{"key":"742_CR244","volume":"2009","author":"T Pringsheim","year":"2009","unstructured":"Pringsheim, T. & Marras, C. Pimozide for tics in Tourette\u2019s syndrome. Cochrane Database Syst. Rev. 2009, CD006996 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"742_CR245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archneur.1984.04050150049015","volume":"41","author":"CG Goetz","year":"1984","unstructured":"Goetz, C. G., Tanner, C. M. & Klawans, H. L. Fluphenazine and multifocal tic disorders. Arch. Neurol. 41, 271\u2013272 (1984).","journal-title":"Arch. Neurol."},{"key":"742_CR246","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/mds.25692","volume":"29","author":"S Wijemanne","year":"2014","unstructured":"Wijemanne, S., Wu, L. J. & Jankovic, J. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov. Disord. 29, 126\u2013130 https:\/\/doi.org\/10.1002\/mds.25692 (2014).","journal-title":"Mov. Disord."},{"key":"742_CR247","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/wnf.0000000000000017","volume":"37","author":"DL Gilbert","year":"2014","unstructured":"Gilbert, D. L., Budman, C. L., Singer, H. S., Kurlan, R. & Chipkin, R. E. A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome. Clin. Neuropharmacol. 37, 26\u201330 https:\/\/doi.org\/10.1097\/wnf.0000000000000017 (2014).","journal-title":"Clin. Neuropharmacol."},{"key":"742_CR248","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-059574","author":"DL Gilbert","year":"2023","unstructured":"Gilbert, D. L. et al. Ecopipam for Tourette syndrome: a randomized trial. Pediatrics https:\/\/doi.org\/10.1542\/peds.2022-059574 (2023).","journal-title":"Pediatrics"},{"key":"742_CR249","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/mdc3.70091","volume":"12","author":"DL Gilbert","year":"2025","unstructured":"Gilbert, D. L. et al. Safety and effect of 12-month ecopipam treatment in pediatric patients with Tourette syndrome. Mov. Disord. Clin. Pract. 12, 1157\u20131166 https:\/\/doi.org\/10.1002\/mdc3.70091 (2025).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR250","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40263-024-01140-w","volume":"39","author":"PK Panda","year":"2025","unstructured":"Panda, P. K. et al. Safety and efficacy of ecopipam in patients with Tourette syndrome: a systematic review and mesyndrome: a systematic review and meta-analysis. CNS Drugs 39, 127\u2013142 https:\/\/doi.org\/10.1007\/s40263-024-01140-w (2025).","journal-title":"CNS Drugs"},{"key":"742_CR251","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/JCP.0000000000000760","volume":"37","author":"T Pringsheim","year":"2017","unstructured":"Pringsheim, T., Ho, J., Sarna, J. R., Hammer, T. & Patten, S. Feasibility and relevance of antipsychotic safety monitoring in children with Tourette syndrome: a prospective longitudinal study. J. Clin. Psychopharmacol. 37, 498\u2013504 (2017).","journal-title":"J. Clin. Psychopharmacol."},{"key":"742_CR252","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","volume":"22","author":"Y Dion","year":"2002","unstructured":"Dion, Y., Annable, L., Sandor, P. & Chouinard, G. Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J. Clin. Psychopharmacol. 22, 31\u201339 (2002).","journal-title":"J. Clin. Psychopharmacol."},{"key":"742_CR253","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","volume":"60","author":"L Scahill","year":"2003","unstructured":"Scahill, L., Leckman, J., Schultz, R., Katsovich, L. & Peterson, B. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60, 1130\u20131135 (2003).","journal-title":"Neurology"},{"key":"742_CR254","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/s2352-4642(22)00316-9","volume":"7","author":"LC Farhat","year":"2023","unstructured":"Farhat, L. C. et al. Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette\u2019s syndrome: a systematic review and network meta-analysis. Lancet Child Adolesc. Health 7, 112\u2013126 https:\/\/doi.org\/10.1016\/s2352-4642(22)00316-9 (2023).","journal-title":"Lancet Child Adolesc. Health"},{"key":"742_CR255","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s004150070173","volume":"247","author":"M Onofrj","year":"2000","unstructured":"Onofrj, M., Paci, C., D\u2019Andreamatteo, G. & Toma, L. Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. J. Neurol. 247, 443\u2013446 (2000).","journal-title":"J. Neurol."},{"key":"742_CR256","first-page":"66","volume":"9","author":"W Ji","year":"2005","unstructured":"Ji, W., Li, Y., Li, N. & Guo, B. Olanzapine for treatment of Tourette syndrome: a double-blind randomized controlled trial. Chin. J. Clin. Rehabil.\u00a09, 66\u201368 (2005).","journal-title":"Chin. J. Clin. Rehabil."},{"key":"742_CR257","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","volume":"39","author":"FR Sallee","year":"2000","unstructured":"Sallee, F. R. et al. Ziprasidone treatment of children and adolescents with Tourette\u2019s syndrome: a pilot study. J. Am. Acad. Child Adolesc. Psychiatry 39, 292\u2013299 (2000).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"742_CR258","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.CHI.0000046897.27264.46","volume":"42","author":"FR Sallee","year":"2003","unstructured":"Sallee, F. R. et al. Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission. J. Am. Acad. Child Adolesc. Psychiatry 42, 902\u2013907 (2003).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"742_CR259","first-page":"154","volume":"25","author":"R Welch","year":"2000","unstructured":"Welch, R. & Chue, P. Antipsychotic agents and QT changes. J. Psychiatry Neurosci. 25, 154\u2013160 (2000).","journal-title":"J. Psychiatry Neurosci."},{"key":"742_CR260","volume":"4","author":"B Coffey","year":"2021","unstructured":"Coffey, B. et al. Efficacy and safety of fixed-dose deutetrabenazine in children and adolescents for tics associated with Tourette syndrome: a randomized clinical trial. JAMA Netw. Open 4, e2129397 (2021).","journal-title":"JAMA Netw. Open"},{"key":"742_CR261","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28204","volume":"4","author":"J Jankovic","year":"2021","unstructured":"Jankovic, J. et al. Safety and efficacy of flexible-dose deutetrabenazine in children and adolescents with Tourette syndrome: a randomized clinical trial. JAMA Netw. Open 4, e2128204 (2021).","journal-title":"JAMA Netw. Open"},{"key":"742_CR262","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/mdc3.13849","volume":"10","author":"J Jankovic","year":"2023","unstructured":"Jankovic, J. et al. Safety and efficacy of long-term deutetrabenazine use in children and adolescents with tics associated with Tourette syndrome: an open-label extension study. Mov. Disord. Clin. Pract. 10, 1388\u20131398 (2023).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR263","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1007\/s00415-023-11769-0","volume":"270","author":"K Makhoul","year":"2023","unstructured":"Makhoul, K. & Jankovic, J. Real-world experience with VMAT2 inhibitors in Tourette syndrome. J. Neurol. 270, 4518\u20134522 (2023).","journal-title":"J. Neurol."},{"key":"742_CR264","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14737175.2021.1898948","volume":"21","author":"RH Farber","year":"2021","unstructured":"Farber, R. H. et al. Clinical development of valbenazine for tics associated with Tourette syndrome. Expert Rev. Neurother. 21, 393\u2013404 https:\/\/doi.org\/10.1080\/14737175.2021.1898948 (2021).","journal-title":"Expert Rev. Neurother."},{"key":"742_CR265","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13010042","volume":"13","author":"C Anandan","year":"2021","unstructured":"Anandan, C. & Jankovic, J. Botulinum toxin in movement disorders: an update. Toxins 13, 42 (2021).","journal-title":"Toxins"},{"key":"742_CR266","doi-asserted-by":"publisher","DOI":"10.1177\/08830738251360210","author":"E Edmondson","year":"2025","unstructured":"Edmondson, E., Hull, M., Aras, S. & Parnes, M. Botulinum toxin for the treatment of motor tics in children: a case series. J. Child Neurol. https:\/\/doi.org\/10.1177\/08830738251360210 (2025).","journal-title":"J. Child Neurol."},{"key":"742_CR267","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mds.870110413","volume":"11","author":"BL Scott","year":"1996","unstructured":"Scott, B. L., Jankovic, J. & Donovan, D. T. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette\u2019s syndrome. Mov. Disord. 11, 431\u2013433 (1996).","journal-title":"Mov. Disord."},{"key":"742_CR268","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11910-022-01177-8","volume":"22","author":"J Frey","year":"2022","unstructured":"Frey, J. & Malaty, I. A. Tourette syndrome treatment updates: a review and discussion of the current and upcoming literature. Curr. Neurol. Neurosci. Rep. 22, 123\u2013142 (2022).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"742_CR269","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","volume":"56","author":"C Marras","year":"2001","unstructured":"Marras, C., Andrews, D., Sime, E. & Lang, A. E. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 56, 605\u2013610 (2001).","journal-title":"Neurology"},{"key":"742_CR270","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/can.2022.0091","volume":"8","author":"E Abi-Jaoude","year":"2023","unstructured":"Abi-Jaoude, E. et al. A double-blind, randomized, controlled crossover trial of cannabis in adults with Tourette syndrome. Cannabis Cannabinoid Res. 8, 835\u2013845 (2023).","journal-title":"Cannabis Cannabinoid Res."},{"key":"742_CR271","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2025.35","volume":"11","author":"V Eapen","year":"2025","unstructured":"Eapen, V. et al. Medicinal cannabis for tics in adolescents with Tourette syndrome. BJPsych Open 11, e145 https:\/\/doi.org\/10.1192\/bjo.2025.35 (2025).","journal-title":"BJPsych Open"},{"key":"742_CR272","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/can.2024.0188","volume":"10","author":"D Efron","year":"2025","unstructured":"Efron, D. et al. A pilot randomized placebo-controlled crossover trial of medicinal cannabis in adolescents with Tourette syndrome. Cannabis Cannabinoid Res. 10, 702\u2013709 (2025).","journal-title":"Cannabis Cannabinoid Res."},{"key":"742_CR273","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/brainsci7050047","volume":"7","author":"AS Kanaan","year":"2017","unstructured":"Kanaan, A. S., Jakubovski, E. & M\u00fcller-Vahl, K. Significant tic reduction in an otherwise treatment-resistant patient with Gilles de la Tourette syndrome following treatment with nabiximols. Brain Sci. 7, 47\u00a0https:\/\/doi.org\/10.3390\/brainsci7050047 (2017).","journal-title":"Brain Sci."},{"key":"742_CR274","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/can.2018.0050","volume":"4","author":"LM Milosev","year":"2019","unstructured":"Milosev, L. M., Psathakis, N., Szejko, N., Jakubovski, E. & M\u00fcller-Vahl, K. R. Treatment of Gilles de la Tourette syndrome with cannabis-based medicine: results from a retrospective analysis and online survey. Cannabis Cannabinoid Res. 4, 265\u2013274 https:\/\/doi.org\/10.1089\/can.2018.0050 (2019).","journal-title":"Cannabis Cannabinoid Res."},{"key":"742_CR275","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300012","volume":"2","author":"PE Mosley","year":"2023","unstructured":"Mosley, P. E. et al. Tetrahydrocannabinol and cannabidiol in Tourette syndrome. NEJM Evid. 2, EVIDoa2300012 (2023).","journal-title":"NEJM Evid."},{"key":"742_CR276","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00228-024-03710-9","volume":"80","author":"I Serag","year":"2024","unstructured":"Serag, I. et al. Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis. Eur. J. Clin. Pharmacol. 80, 1483\u20131493 https:\/\/doi.org\/10.1007\/s00228-024-03710-9 (2024).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"742_CR277","volume":"323","author":"KR M\u00fcller-Vahl","year":"2023","unstructured":"M\u00fcller-Vahl, K. R. et al. CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders \u2014 results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study. Psychiatry Res. 323, 115135 (2023).","journal-title":"Psychiatry Res."},{"key":"742_CR278","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1021\/acs.jmedchem.8b01405","volume":"61","author":"M Jiang","year":"2018","unstructured":"Jiang, M. & van der Stelt, M. Activity-based protein profiling delivers selective drug candidate ABX-1431, a monoacylglycerol lipase inhibitor, to control lipid metabolism in neurological disorders. J. Med. Chem. 61, 9059\u20139061 https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01405 (2018).","journal-title":"J. Med. Chem."},{"key":"742_CR279","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5603\/PJNNS.a2021.0081","volume":"56","author":"N Szejko","year":"2022","unstructured":"Szejko, N., Saramak, K., Lombroso, A. & M\u00fcller-Vahl, K. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome. Neurol. Neurochir. Pol. 56, 28\u201338 https:\/\/doi.org\/10.5603\/PJNNS.a2021.0081 (2022).","journal-title":"Neurol. Neurochir. Pol."},{"key":"742_CR280","doi-asserted-by":"publisher","unstructured":"Sahin, I. A. et al. Optimal deep brain stimulation locations for Gilles de la Tourette syndrome. Preprint at medRxiv https:\/\/doi.org\/10.64898\/2026.02.21.26346772 (2026).","DOI":"10.64898\/2026.02.21.26346772"},{"key":"742_CR281","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10143-024-02958-0","volume":"47","author":"S Aydin","year":"2024","unstructured":"Aydin, S., Darko, K., Jenkins, A., Detchou, D. & Barrie, U. Deep brain stimulation for Tourette\u2019s syndrome. Neurosurgical Rev. 47, 734 (2024).","journal-title":"Neurosurgical Rev."},{"key":"742_CR282","doi-asserted-by":"crossref","DOI":"10.1088\/1741-2552\/ae1257","volume":"22","author":"S Haslam","year":"2025","unstructured":"Haslam, S., Johnson, K., Anderson, D. N., Mahant, N. & Anderson, C. J. Neuromodulation for Tourette syndrome: current techniques and future perspectives. J. Neural Eng. 22, 061001 (2025).","journal-title":"J. Neural Eng."},{"key":"742_CR283","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/jamaneurol.2017.4317","volume":"75","author":"D Martinez-Ramirez","year":"2018","unstructured":"Martinez-Ramirez, D. et al. Efficacy and safety of deep brain stimulation in Tourette syndrome: the International Tourette Syndrome Deep Brain Stimulation Public Database and Registry. JAMA Neurol. 75, 353\u2013359 https:\/\/doi.org\/10.1001\/jamaneurol.2017.4317 (2018).","journal-title":"JAMA Neurol."},{"key":"742_CR284","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57071-5","volume":"14","author":"MS Okun","year":"2024","unstructured":"Okun, M. S. et al. Responsive deep brain stimulation for the treatment of Tourette syndrome. Sci. Rep. 14, 6467 https:\/\/doi.org\/10.1038\/s41598-024-57071-5 (2024).","journal-title":"Sci. Rep."},{"key":"742_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00360","volume":"21","author":"A Zhang","year":"2024","unstructured":"Zhang, A. et al. Efficacy of deep brain stimulation for Tourette syndrome and its comorbidities: a meta-analysis. Neurotherapeutics 21, e00360 https:\/\/doi.org\/10.1016\/j.neurot.2024.e00360 (2024).","journal-title":"Neurotherapeutics"},{"key":"742_CR286","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s1474-4422(22)00303-9","volume":"22","author":"KA Johnson","year":"2023","unstructured":"Johnson, K. A. et al. Tourette syndrome: clinical features, pathophysiology, and treatment. Lancet Neurol. 22, 147\u2013158 https:\/\/doi.org\/10.1016\/s1474-4422(22)00303-9 (2023).","journal-title":"Lancet Neurol."},{"key":"742_CR287","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00221-021-06229-y","volume":"240","author":"K Dyke","year":"2022","unstructured":"Dyke, K., Jackson, G. & Jackson, S. Non-invasive brain stimulation as therapy: systematic review and recommendations with a focus on the treatment of Tourette syndrome. Exp. Brain Res. 240, 341\u2013363 https:\/\/doi.org\/10.1007\/s00221-021-06229-y (2022).","journal-title":"Exp. Brain Res."},{"key":"742_CR288","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/14737175.2025.2548330","volume":"25","author":"J Frey","year":"2025","unstructured":"Frey, J. & Malaty, I. An overview of transcranial direct current stimulation for tic symptoms in Tourette\u2019s syndrome. Expert Rev. Neurother. 25, 1165\u20131173 https:\/\/doi.org\/10.1080\/14737175.2025.2548330 (2025).","journal-title":"Expert Rev. Neurother."},{"key":"742_CR289","doi-asserted-by":"crossref","unstructured":"Houlgreave, M. S., Dyke, K. & Jackson, S. R. in Handbook of Clinical Neurology Vol. 215: Tic Disorders and Tourette Syndrome (eds Ganos, C. & Worbe, Y.) 299\u2013310 (Elsevier, 2026).","DOI":"10.1016\/B978-0-443-13554-5.00012-2"},{"key":"742_CR290","volume":"222","author":"B Liang","year":"2025","unstructured":"Liang, B. et al. Role and related mechanisms of non-invasive brain stimulation in the treatment of Tourette syndrome. Brain Res. Bull. 222, 111258 (2025).","journal-title":"Brain Res. Bull."},{"key":"742_CR291","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mdc3.14285","volume":"12","author":"Y Mahjoub","year":"2025","unstructured":"Mahjoub, Y. et al. Randomized controlled trial of transcranial direct current stimulation over the supplementary motor area in Tourette syndrome. Mov. Disord. Clin. Pract. 12, 313\u2013324 https:\/\/doi.org\/10.1002\/mdc3.14285 (2025).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR292","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1478503","volume":"16","author":"AK Aloufi","year":"2025","unstructured":"Aloufi, A. K. et al. Tourette syndrome and brain stimulation therapy: a systematic review and meta-analysis of current evidence. Front. Psychiatry 16, 1478503 (2025).","journal-title":"Front. Psychiatry"},{"key":"742_CR293","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpsychires.2024.02.057","volume":"173","author":"ER Steuber","year":"2024","unstructured":"Steuber, E. R. & McGuire, J. F. A meta-analysis of transcranial magnetic stimulation in Tourette syndrome. J. Psychiatr. Res. 173, 34\u201340 (2024).","journal-title":"J. Psychiatr. Res."},{"key":"742_CR294","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.wnn.0000116253.78804.3a","volume":"17","author":"J-H Chae","year":"2004","unstructured":"Chae, J.-H. et al. A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette\u2019s syndrome. Cognit. Behav. Neurol. 17, 109\u2013117 (2004).","journal-title":"Cognit. Behav. Neurol."},{"key":"742_CR295","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinph.2004.10.003","volume":"116","author":"M Orth","year":"2005","unstructured":"Orth, M. et al. Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome. Clin. Neurophysiol. 116, 764\u2013768 (2005).","journal-title":"Clin. Neurophysiol."},{"key":"742_CR296","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/dmcn.14828","volume":"63","author":"CK Kahl","year":"2021","unstructured":"Kahl, C. K. et al. Bilateral transcranial magnetic stimulation of the supplementary motor area in children with Tourette syndrome. Dev. Med. Child Neurol. 63, 808\u2013815 (2021).","journal-title":"Dev. Med. Child Neurol."},{"key":"742_CR297","volume":"11","author":"M Kleimaker","year":"2020","unstructured":"Kleimaker, M. et al. Non-invasive brain stimulation for the treatment of Gilles de la Tourette syndrome. Front. Neurol. 11, 592258 (2020).","journal-title":"Front. Neurol."},{"key":"742_CR298","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.brs.2014.11.015","volume":"8","author":"A Landeros-Weisenberger","year":"2015","unstructured":"Landeros-Weisenberger, A. et al. Randomized sham controlled double-blind trial of repetitive transcranial magnetic stimulation for adults with severe Tourette syndrome. Brain Stimul. 8, 574\u2013581 https:\/\/doi.org\/10.1016\/j.brs.2014.11.015 (2015).","journal-title":"Brain Stimul."},{"key":"742_CR299","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4103\/IJPSYM.IJPSYM_332_17","volume":"40","author":"S Singh","year":"2018","unstructured":"Singh, S., Kumar, S., Kumar, N. & Verma, R. Low-frequency repetitive transcranial magnetic stimulation for treatment of Tourette syndrome: a naturalistic study with 3 months of follow-up. Indian. J. Psychological Med. 40, 482\u2013486 (2018).","journal-title":"Indian. J. Psychological Med."},{"key":"742_CR300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S1092852918000834","volume":"23","author":"AE Cavanna","year":"2018","unstructured":"Cavanna, A. E. Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder. CNS Spectr. 23, 213\u2013218 (2018).","journal-title":"CNS Spectr."},{"key":"742_CR301","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/bs.irn.2017.05.006","volume":"134","author":"D Martino","year":"2017","unstructured":"Martino, D., Ganos, C. & Pringsheim, T. M. Tourette syndrome and chronic tic disorders: the clinical spectrum beyond tics. Int. Rev. Neurobiol. 134, 1461\u20131490 (2017).","journal-title":"Int. Rev. Neurobiol."},{"key":"742_CR302","volume":"346","author":"JMH Suasnabar","year":"2024","unstructured":"Suasnabar, J. M. H., Finch, A. P., Mulhern, B. & van den Akker-van, M. E. Exploring the measurement of health related quality of life and broader instruments: a dimensionality analysis. Soc. Sci. Med. 346, 116720 (2024).","journal-title":"Soc. Sci. Med."},{"key":"742_CR303","first-page":"123","volume":"48","author":"AE Cavanna","year":"2025","unstructured":"Cavanna, A. E. Quality of life in Tourette syndrome. Psychiatr. Clin. 48, 123\u2013150 (2025).","journal-title":"Psychiatr. Clin."},{"key":"742_CR304","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.619854","volume":"12","author":"DA Isaacs","year":"2021","unstructured":"Isaacs, D. A., Riordan, H. R. & Claassen, D. O. Clinical correlates of health-related quality of life in adults with chronic tic disorder. Front. Psychiatry 12, 619854 (2021).","journal-title":"Front. Psychiatry"},{"key":"742_CR305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.comppsych.2018.04.008","volume":"84","author":"H Weingarden","year":"2018","unstructured":"Weingarden, H. et al. Self-esteem in adults with Tourette syndrome and chronic tic disorders: the roles of tic severity, treatment, and comorbidity. Compr. Psychiatry 84, 95\u2013100 (2018).","journal-title":"Compr. Psychiatry"},{"key":"742_CR306","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mds.28301","volume":"36","author":"D Mataix-Cols","year":"2021","unstructured":"Mataix-Cols, D. et al. Serious transport accidents in Tourette syndrome or chronic tic disorder. Mov. Disord. 36, 188\u2013195 https:\/\/doi.org\/10.1002\/mds.28301 (2021).","journal-title":"Mov. Disord."},{"key":"742_CR307","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mdc3.13177","volume":"8","author":"H Ringberg","year":"2021","unstructured":"Ringberg, H., Anderson, S., Stern, J. & Mataix-Cols, D. Driving with tic disorders: an international survey of lived experiences. Mov. Disord. Clin. Pract. 8, 412\u2013419 (2021).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR308","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10072-016-2682-y","volume":"37","author":"PR Silvestri","year":"2016","unstructured":"Silvestri, P. R. et al. Health-related quality of life in patients with Gilles de la Tourette syndrome at the transition between adolescence and adulthood. Neurol. Sci. 37, 1857\u20131860 (2016).","journal-title":"Neurol. Sci."},{"key":"742_CR309","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/01.wnl.0000327890.02893.61","volume":"71","author":"AE Cavanna","year":"2008","unstructured":"Cavanna, A. E. et al. The Gilles de la Tourette syndrome \u2014 quality of life scale (GTS-QOL) development and validation. Neurology 71, 1410\u20131416 (2008). This paper describes the first disease-specific health-related quality of life measure for patients with TS.","journal-title":"Neurology"},{"key":"742_CR310","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/mds.29868","volume":"39","author":"M Sarchioto","year":"2024","unstructured":"Sarchioto, M. et al. Diagnostic criteria for primary tic disorders: time for reappraisal. Mov. Disord. 39, 1276\u20131281 https:\/\/doi.org\/10.1002\/mds.29868 (2024). This paper is notable because it reflects a move towards redefining tic disorders, which has implications for how we approach clinical care and research.","journal-title":"Mov. Disord."},{"key":"742_CR311","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/mdc3.13977","volume":"11","author":"C Nilles","year":"2024","unstructured":"Nilles, C., Martino, D., Berg, L., Fletcher, J. & Pringsheim, T. What are the key phenomenological clues to diagnose functional tic-like behaviors in the pandemic era? Mov. Disord. Clin. Pract. 11, 398\u2013402 https:\/\/doi.org\/10.1002\/mdc3.13977 (2024).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"742_CR312","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1007\/s00787-025-02732-7","volume":"34","author":"C Nilles","year":"2025","unstructured":"Nilles, C., Martino, D., Fletcher, J., Sarna, J. R. & Pringsheim, T. Challenging current diagnostic and classification criteria for primary tic disorders. Eur. Child Adolesc. Psychiatry 34, 3883\u20133890 https:\/\/doi.org\/10.1007\/s00787-025-02732-7 (2025).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"742_CR313","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/wnl.0000000000007467","volume":"92","author":"T Pringsheim","year":"2019","unstructured":"Pringsheim, T. et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92, 907\u2013915 https:\/\/doi.org\/10.1212\/wnl.0000000000007467 (2019).","journal-title":"Neurology"},{"key":"742_CR314","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/pl00007984","volume":"84","author":"K Gurney","year":"2001","unstructured":"Gurney, K., Prescott, T. J. & Redgrave, P. A computational model of action selection in the basal ganglia. I. A new functional anatomy. Biol. Cybern. 84, 401\u2013410 https:\/\/doi.org\/10.1007\/pl00007984 (2001).","journal-title":"Biol. Cybern."},{"key":"742_CR315","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jamaneurol.2026.1431","volume":"83","author":"DL Gilbert","year":"2026","unstructured":"Gilbert, D. L. et al. Efficacy and safety of ecopipam for Tourette Syndrome: a phase 3 randomized clinical trial. JAMA Neurol. 83, 645\u2013653 (2026).","journal-title":"JAMA Neurol."},{"key":"742_CR316","doi-asserted-by":"publisher","first-page":"pyw030","DOI":"10.1093\/ijnp\/pyw030","volume":"19","author":"PRA Heckman","year":"2016","unstructured":"Heckman, P. R. A. et al. Phosphodiesterase inhibition and regulation of dopaminergic frontal and striatal functioning: clinical implications. Int. J. Neuropsychopharmacol. 19, pyw030 https:\/\/doi.org\/10.1093\/ijnp\/pyw030 (2016).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"742_CR317","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2015.01.001","volume":"265","author":"V Pogorelov","year":"2015","unstructured":"Pogorelov, V., Xu, M., Smith, H. R., Buchanan, G. F. & Pittenger, C. Corticostriatal interactions in the generation of tic-like behaviors after local striatal disinhibition. Exp. Neurol. 265, 122\u2013128 (2015).","journal-title":"Exp. Neurol."},{"key":"742_CR318","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020175","volume":"11","author":"R Cadeddu","year":"2021","unstructured":"Cadeddu, R. et al. The \u03b16 GABAA receptor positive allosteric modulator DK-I-56-1 reduces tic-related behaviors in mouse models of Tourette syndrome. Biomolecules 11, 175 (2021).","journal-title":"Biomolecules"},{"key":"742_CR319","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105637","volume":"160","author":"C Branca","year":"2024","unstructured":"Branca, C. & Bortolato, M. The role of neuroactive steroids in tic disorders. Neurosci. Biobehav. Rev. 160, 105637 (2024).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"742_CR320","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.cub.2020.04.044","volume":"30","author":"BM Maiquez","year":"2020","unstructured":"Maiquez, B. M. et al. Entraining movement-related brain oscillations to suppress tics in Tourette syndrome. Curr. Biol. 30, 2334\u20132342.e3 (2020).","journal-title":"Curr. Biol."},{"key":"742_CR321","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/jnp.12313","volume":"17","author":"BM Maiquez","year":"2023","unstructured":"Maiquez, B. M. et al. A double-blind, sham-controlled, trial of home-administered rhythmic 10-Hz median nerve stimulation for the reduction of tics, and suppression of the urge-to-tic, in individuals with Tourette syndrome and chronic tic disorder. J. Neuropsychol. 17, 540\u2013563 (2023).","journal-title":"J. Neuropsychol."},{"key":"742_CR322","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/mds.22724","volume":"24","author":"K Kompoliti","year":"2009","unstructured":"Kompoliti, K., Fan, W. & Leurgans, S. Complementary and alternative medicine use in Gilles de la Tourette syndrome. Mov. Disord. 24, 2015\u20132019 https:\/\/doi.org\/10.1002\/mds.22724 (2009).","journal-title":"Mov. Disord."},{"key":"742_CR323","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/mds.70044","volume":"40","author":"F Proietti","year":"2025","unstructured":"Proietti, F. et al. Vagus nerve stimulation in movement disorders, from principles to a systematic review of evidence. Mov. Disord. 40, 2559\u20132577 (2025).","journal-title":"Mov. Disord."},{"key":"742_CR324","unstructured":"Singer, H. S. in Handbook of Clinical Neurology Vol. 100: Hyperkinetic Movement Disorders (eds Weiner, W. J. & Tolosa, E.) 641\u2013657 (Elsevier, 2011)."},{"key":"742_CR325","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neubiorev.2021.08.001","volume":"129","author":"J Garris","year":"2021","unstructured":"Garris, J. & Quigg, M. The female Tourette patient: sex differences in Tourette disorder. Neurosci. Biobehav. Rev. 129, 261\u2013268 https:\/\/doi.org\/10.1016\/j.neubiorev.2021.08.001 (2021).","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00742-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00742-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00742-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:34:04Z","timestamp":1792085644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00742-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":325,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["742"],"URL":"https:\/\/doi.org\/10.1038\/s41572-026-00742-6","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"4 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, in the \u201cComorbidities\u201d row of Table 2, the entries for \u201cTS\u201d and \u201cFTD\u201d were switched and have now been corrected so that \u201cADHD and OCD\u201d is in the \u201cTS\u201d column and \u201cEmotional arousal, anxiety and depression\u201d is in the \u201cFTD\u201d column. This correction has been made to the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"66"}}